WO2024067774A1 - Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof - Google Patents

Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof Download PDF

Info

Publication number
WO2024067774A1
WO2024067774A1 PCT/CN2023/122447 CN2023122447W WO2024067774A1 WO 2024067774 A1 WO2024067774 A1 WO 2024067774A1 CN 2023122447 W CN2023122447 W CN 2023122447W WO 2024067774 A1 WO2024067774 A1 WO 2024067774A1
Authority
WO
WIPO (PCT)
Prior art keywords
gene
strain
saccharomyces cerevisiae
promoter
bar1
Prior art date
Application number
PCT/CN2023/122447
Other languages
French (fr)
Chinese (zh)
Inventor
刘巍峰
徐明远
张伟欣
孟祥锋
Original Assignee
山东大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN202211192432.8A external-priority patent/CN115806889B/en
Priority claimed from CN202211193388.2A external-priority patent/CN115806890A/en
Application filed by 山东大学 filed Critical 山东大学
Publication of WO2024067774A1 publication Critical patent/WO2024067774A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae

Definitions

  • the invention belongs to the field of biotechnology, and in particular relates to an engineering bacterium of brewer's yeast with improved gene expression level, and a construction method and application thereof.
  • Saccharomyces cerevisiae also known as baker's yeast
  • Saccharomyces cerevisiae has long been used in brewing, bread and steamed bun making, etc. It is safe and reliable, does not produce toxins, and is an internationally recognized food safety grade (Generally Considered As Safe, GRAS) eukaryotic microorganism. Because its bacterial cells are rich in nutrients and have high economic value, yeast extracts or yeast extracts (Yeast Extract) are not only widely used in microbial, animal and plant cell culture, but also play an important role in pharmaceutical, brewing and fermented foods, and are also directly used in feed and food additives.
  • Yeast has good fermentation properties in industrial production, can divide quickly during the fermentation process, is easy to culture, has strong resistance to bacterial contamination, has a clear genetic background, and is simple to operate. Therefore, it is often used as a starting strain for metabolic engineering in genetic engineering technology.
  • Saccharomyces cerevisiae has become a chassis strain that has attracted much attention due to its special metabolic capabilities and other characteristics, and is often used to synthesize heterologous high value-added products.
  • the constitutive expression of genes related to the heterologous metabolite pathway usually leads to excessive consumption of cellular resources and inhibits cell growth, thus affecting the final yield of the target product.
  • induction regulation methods such as galactose-inducible promoters induce heterologous pathway gene expression, and add inducer galactose after the cell concentration reaches a certain value, thereby avoiding excessive resource consumption in the early stage of cell growth.
  • inducers such as galactose are very expensive, and the cost of industrial production is high.
  • Saccharomyces cerevisiae has an endogenous pheromone-mediated transcriptional regulation system related to cell mating. Therefore, a gene expression regulation system can be constructed based on the endogenous pheromone response pathway of Saccharomyces cerevisiae to achieve the expression of exogenous genes. However, when using this system to express exogenous genes, the expression level of the exogenous genes will be lower than the gene expression level driven by the promoter P gal1 of the galactose metabolism regulation system, and it is not suitable for the synthesis of heterologous metabolites.
  • the concentration threshold of the quorum sensing system based on the endogenous pheromone S ⁇ of Saccharomyces cerevisiae is low, and when activated, the cell cycle will be blocked in the G1 phase, severely inhibiting cell growth, which is not conducive to the preparation of heterologous metabolites. Therefore, it is very necessary to further construct an engineered strain of Saccharomyces cerevisiae that improves the gene expression level.
  • the present invention provides an engineering yeast of Saccharomyces cerevisiae for improving the gene expression level and a construction method and application thereof.
  • An engineered yeast strain for improving gene expression level is based on the yeast strain W303-1a, in which the extracellular protease encoding gene bar1 and the galactose metabolic pathway inhibitor encoding gene gal80 are knocked out. It also contains the K ⁇ factor encoding gene kmf ⁇ 1 from Kluyveromyces lactis expressed by the promoter P vrg4 and the transcription activator encoding gene gal4 expressed by the promoter P fus1 .
  • the method for constructing the above-mentioned brewer's yeast engineering bacteria comprises the steps of: using brewer's yeast W303-1a as the starting strain, knocking out the bar1 gene, then transforming the recombinant vector pRS304-P vrg4 -kmf ⁇ 1-T cyc1 containing the promoter P vrg4 and the K ⁇ factor encoding gene kmf ⁇ 1, replacing the original promoter of the gal4 encoding gene with P fus1 , then transforming the fusion fragment P fus1 -gal4, and finally knocking out the gal80 gene, and obtaining it through screening and verification.
  • the method for constructing an engineered strain of Saccharomyces cerevisiae for improving the gene expression level comprises the following steps:
  • kanMX geneticin marker gene with loxp sequences (CRE enzyme cleavage sites) at both ends in the plasmid pUMRI-A as a template
  • PCR amplification was performed with Bar1-g418-UP-F and Bar1-g418-down-R as primers to obtain the knockout component of the bar1 gene; then the knockout component of the bar1 gene was transformed into the Saccharomyces cerevisiae strain W303-1a, and after screening, the strain Bar1 ⁇ in which the gene encoding the extracellular protease Bar1 was knocked out was obtained;
  • the Bar1-g418-UP-F carries a 50 bp homology arm upstream of bar1
  • the Bar1-g418-down-R carries a 50 bp homology arm downstream of bar1 and the specific sequences are as follows:
  • Bar1-g418-UP-F 5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′,
  • Bar1-g418-down-R 5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′.
  • step (1) the sequence of loxP is as follows:
  • Loxp 5′-ATAACTTCGTATAGCATACATTATACGAAGTTAT-3′.
  • the ⁇ factor is from Kluyveromyces
  • the nucleotide sequence is shown in SEQ ID NO.1
  • the PCR amplification primer sequence is as follows:
  • KMFa1-F 5′-ATGAAATTCTCTACTATATTAG-3′
  • KMFa1-R 5′-ATTACATGATCAGAAAATTGGTTGGCC-3′.
  • step (2) the PCR amplification primer sequence of the promoter P vrg4 is as follows:
  • the PCR primer sequence of the terminator T cyc1 is as follows:
  • CYC1t-kmfa1-F 5′-CAATTTTCTGATCATGTAATTAGTTATG-3′;
  • step (3) the PCR primer sequence of the promoter P fus1 with the downstream homology arm of the promoter P gal4 is as follows:
  • fus1-down-pGal4-R 5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′;
  • the PCR amplification primer sequence of the kanMX geneticin marker gene with the upstream homology arm of the promoter P gal4 is as follows:
  • UP-Pgal4-G418-F 5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′,
  • G418-fus-R 5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′.
  • step (3) the molar ratio of the promoter P fus1 and the transcription activator gal4 in the fusion PCR is 1:1.
  • the Gal80-knockout-F carries a 50 bp homology arm upstream of gal80
  • the Gal80-knockout-R carries a 50 bp homology arm downstream of gal80
  • Gal80-knockout-F 5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′;
  • Gal80-knockout-R 5′-TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′.
  • the genetically engineered bacteria expressing the exogenous gene is a strain containing the exogenous gene or a vector containing the exogenous gene, and the exogenous gene is integrated into the genome of the strain.
  • the exogenous gene is a coding sequence of a protein used in the field of industry, feed or food.
  • the exogenous gene is a coding sequence of an enzyme, and the enzyme is a glycosyltransferase.
  • the exogenous gene is an ⁇ -1,3-fucosyltransferase gene or an ⁇ -1,2-fucosyltransferase gene.
  • a genetically engineered bacterium with high yield of 3-fucosyllactose wherein the genetically engineered bacterium simultaneously expresses lactose permease, GDP-mannose dehydrogenase, GDP-fucose synthase and alpha-1,3-fucosyltransferase.
  • the genetically engineered bacteria is a recombinant Saccharomyces cerevisiae
  • Saccharomyces cerevisiae is Saccharomyces cerevisiae W303-1a
  • the genotype of the Saccharomyces cerevisiae W303-1a is MATa ade2-1 can1-100 ura3-1 leu2-3,112 his3-11,15.
  • the lactose permease is a lactose permease from Kluyveromyces cerevisiae, the encoding gene of which is Lac12 and the Genbank accession number is X06997.1.
  • the GDP-mannose dehydrogenase is GDP-mannose dehydrogenase from Escherichia coli K12, whose encoding gene is Gmd and whose Genbank accession number is WP_182915037.1.
  • the GDP-fucose synthase is the GDP-fucose synthase from Escherichia coli K12, the encoding gene of which is WcaG, and the Genbank accession number is WP_000043654.1.
  • the present invention forms a QS-EGE2 system with promoter P vrg4 , ⁇ factor kmf ⁇ 1, promoter P fus1 and transcription activator gal4, and then constructs the system in Saccharomyces cerevisiae in which the extracellular protease encoding gene bar1 and the transcription repressor encoding gene gal80 are knocked out.
  • Saccharomyces cerevisiae the K ⁇ factor derived from Kluyveromyces is expressed with the weak promoter P vrg4 , which significantly reduces the inhibition of cell growth caused by the activation of the Saccharomyces cerevisiae ⁇ pheromone regulatory system.
  • the P fus1 with a higher transcription level in the activated system is used to drive the expression of the transcription activator gal4 of the galactose metabolic pathway, and then gal4 is used to further activate the target gene expressed by the promoter P gal , thereby achieving the effect of significantly improving the gene expression level.
  • Knocking out bar1 can prevent the degradation of the ⁇ factor secreted to the extracellular space, and knocking out gal80 can relieve the inhibitory effect of the galactose metabolic pathway, further amplifying the output level of the system.
  • the present invention simultaneously expresses lactose permease, GDP-mannose dehydrogenase, GDP-fucose synthase and ⁇ -1,3-fucosyltransferase in Saccharomyces cerevisiae, and constructs a new genetically engineered bacterium. Since the ⁇ -1,3-fucosyltransferase Fut3Bc is an optimized codon, the efficiency of synthesizing 3-FL is higher and it is more suitable for expression in Saccharomyces cerevisiae.
  • the yield of 3-FL is greatly improved, and the yield can reach 0.93 g/L, which is 5.4 times that of the commonly used ⁇ -1,3-FT FutA strain for synthesizing 3-FL that has been reported, providing important reference and guidance for the industrial synthesis of 3-FL.
  • the present invention is based on the pheromone sensing system composed of the endogenous promoter P fus1 of Saccharomyces cerevisiae and the transcription activator gal4 sequence.
  • the promoter P vrg4 By combining the expression of the heterologous pheromone ⁇ factor kmf ⁇ 1 with the amplification of the transcription signal, the promoter P vrg4 ,
  • the QS-EGE2 system consists of the ⁇ factor kmf ⁇ 1, the promoter P fus1 and the transcription activator gal4. This system can achieve high-level expression of exogenous genes. And on the basis of efficient expression of exogenous genes, it avoids the inhibition of cell growth by the endogenous ⁇ factor of Saccharomyces cerevisiae.
  • the saccharomyces cerevisiae engineered bacteria provided by the present invention that improve the gene expression level contains a gene expression regulation system (QS-EGE2 system), which can be used to regulate heterologous product pathway-related enzymes including glycosyltransferases, and can enhance their expression levels to thereby improve the efficiency of target product synthesis.
  • QS-EGE2 system gene expression regulation system
  • the QS-EGE2 system Compared with the galactose-inducible promoter commonly used in saccharomyces cerevisiae to synthesize heterologous products, the QS-EGE2 system provided by the present invention does not require additional galactose-induced gene expression, and can achieve efficient gene expression under a low-cost glucose carbon source, and the gene expression level is 2.7 times that of the galactose-inducible promoter P gal1 .
  • FIG1 is a schematic diagram of the construction of strain K ⁇ -EGE2.
  • FIG. 2 is a diagram showing the strength of the gene expression regulation system in the engineered bacteria K ⁇ -FUS1p-GFP.
  • FIG. 3 is a diagram showing the intensity of the QS-EGE2 system in the engineered bacteria K ⁇ -EGE2-GFP.
  • the left figure shows the growth curves of K ⁇ -EGE2-GFP and the strain gal-GFP expressing GFP only with a galactose-inducible promoter under glucose carbon source and galactose carbon source respectively;
  • the right figure shows the GFP expression intensity in the strain gal-GFP under K ⁇ -EGE2-GFP and galactose induction.
  • FIG. 4 is a schematic diagram of the construction of strain K ⁇ -EGE3-GFP.
  • FIG. 5 is a diagram showing the intensity of the QS-EGE3 system in the engineered bacteria EGE3-GFP.
  • the left figure shows the growth curves of K ⁇ -EGE2-GFP and K ⁇ -EGE3-GFP under glucose culture
  • the right figure shows the GFP expression intensity in K ⁇ -EGE2-GFP and K ⁇ -EGE3-GFP under glucose culture.
  • FIG6 is a graph showing the 2′-FL yield in the fermentation products of strain K ⁇ -EGE4-2FL and control strain FL06.
  • the left figure shows the growth curves of K ⁇ -EGE4-2FL cultured in glucose and the control strain FL06 cultured in galactose
  • the right figure shows the 2’-FL yield in K ⁇ -EGE4-2FL cultured in glucose and the control strain FL06 cultured in galactose.
  • FIG. 7 is a graph showing the 3′-FL yield in the fermentation products of strain K ⁇ -EGE4-2FL and control strain FL303.
  • the left figure shows the growth curves of K ⁇ -EGE4-3FL cultured in glucose and the control strain FL303 cultured in galactose
  • the right figure shows the 3-FL production in K ⁇ -EGE4-3FL cultured in glucose and the control strain FL303 cultured in galactose.
  • Saccharomyces cerevisiae W303-1a used in the present invention is a common commercial strain, which can be purchased from a microbial collection center or a strain sales company.
  • PCR amplification was performed using primers Bar1-g418-UP-F with a 50bp homology arm upstream of bar1 and Bar1-g418-down-R with a 50bp homology arm downstream of bar1 to obtain the knockout component of the bar1 gene (SEQ ID NO.6).
  • the specific sequences of the primers are as follows:
  • Bar1-g418-UP-F 5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′,
  • Bar1-g418-down-R 5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′;
  • PCR amplification system Use high-fidelity DNA polymerase Phanta Super-Fidelity DNA Polymerase purchased from Vazyme, and the PCR amplification system is prepared according to the instructions of the kit.
  • PCR amplification program pre-denaturation at 95°C for 3 min, denaturation at 95°C for 15 s, annealing at 55°C for 15 s, extension at 72°C for 1 min/kb, 30 cycles, post-extension at 72°C for 5 min, and storage at 12°C.
  • the knockout component of the bar1 gene was transformed into the Saccharomyces cerevisiae strain W303-1a. After screening positive transformants on YPD solid medium with 200 ⁇ g/mL of G418 antibiotic, the strain Bar1 ⁇ in which the gene encoding the extracellular protease Bar1 was knocked out was obtained.
  • the components of the YPD solid culture medium are: 20 g/L glucose, 20 g/L peptone, and 10 g/L yeast extract.
  • the ⁇ -factor encoding gene kmf ⁇ 1 sequence from Kluyveromyces was codon-optimized for Saccharomyces cerevisiae, and then the corresponding encoding gene sequence was synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd.
  • the sequence was used as a template for PCR amplification to obtain the optimized kmf ⁇ 1 sequence (SEQ ID NO.1).
  • the PCR amplification primer sequences are as follows:
  • KMFa1-F 5′-ATGAAATTCTCTACTATATTAG-3′
  • KMFa1-R 5′-ATTACATGATCAGAAAATTGGTTGGCC-3′.
  • the genomic DNA of Saccharomyces cerevisiae W303-1a was used as a template for PCR amplification to obtain the promoter P vrg4 and the terminator T cyc1 .
  • the sequences of the PCR amplification primers are as follows:
  • CYC1t-kmfa1-F 5′-CAATTTTCTGATCATGTAATTAGTTATG-3′;
  • P vrg4 the optimized kmf ⁇ 1 sequence and T cyc1 were fused by PCR at a molar ratio of 1:3:1 to obtain the fusion PCR product P vrg4 -kmf ⁇ 1-T cyc1 ;
  • P vrg4 -kmf ⁇ 1-T cyc1 was ligated between the XhoI and BamHI sites of plasmid pRS304 by T5 exonuclease ligation to obtain the recombinant vector pRS304-P vrg4 -kmf ⁇ 1-T cyc1 ;
  • the recombinant vector pRS304-P vrg4 -kmf ⁇ 1-T cyc1 was linearized with endonuclease Bsu36I, and then transformed into the strain Bar1 ⁇ , and screened by tryptophan-deficient SC solid culture medium to obtain the strain VRG4p-K ⁇ .
  • the fusion PCR was completed using the VazymePhanta Super-Fidelity DNA Polymerase Kit, and the fusion PCR system was prepared according to the instructions of the kit.
  • the nucleotide sequence of the promoter P vrg4 is shown in SEQ ID NO.3, and the nucleotide sequence of the terminator T cyc1 is shown in SEQ ID NO.5.
  • the promoter P fus1 fragment with the downstream homology arm of the promoter P gal4 was amplified; using the plasmid pUMRI-A as a template, the kanMX geneticin marker gene with the upstream homology arm of the promoter P gal4 was amplified.
  • the PCR primer sequences are as follows:
  • fus1-down-pGal4-R 5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′;
  • UP-Pgal4-G418-F 5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′,
  • G418-fus-R 5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′.
  • the vector YEp-CH with Cre recombinase was transformed into the engineering bacteria VRG4p-K ⁇ , and screened on YPD solid medium with 200 ⁇ g/mL hygromycin antibiotics. The obtained transformants were induced by galactose to express Cre recombinase, and the kanMX geneticin marker gene between the loxp sites was removed.
  • the promoter P fus1 and kanMX sequences were fused by PCR at a molar ratio of 1:1 to obtain the fusion PCR product P fus1 -gal4 fragment; the P fus1 -gal4 fragment was transformed into the strain VRG4p-K ⁇ , and the positive transformants were screened on YPD solid medium with 200 ⁇ g/mL G418 antibiotics to obtain the strain K ⁇ -EGE1.
  • nucleotide sequence of the promoter P fus1 is shown in SEQ ID NO.4; the nucleotide sequence of the P fus1 -gal4 fragment is shown in SEQ ID NO.7
  • the engineered bacteria K ⁇ -EGE1 obtained in this step contains the QS-EGE1 system composed of the promoter P vrg4 , the ⁇ factor kmf ⁇ 1 and the element P fus1 -gal4 .
  • PCR amplification primer sequences are as follows:
  • Gal80-knockout-F 5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′;
  • Gal80-knockout-R 5′-TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′.
  • the vector YEp-CH carrying the Cre recombinase was transformed into the engineered bacteria K ⁇ -EGE1 and screened on a YPD solid culture medium containing 200 ⁇ g/mL of hygromycin antibiotics.
  • the obtained transformants were induced to express the Cre recombinase by galactose, the kanMX geneticin marker gene between the loxp sites was removed, and then the knockout component of the gal80 gene was transformed into the strain.
  • Positive transformants were screened on a plate containing 200 ⁇ g/mL of G418 antibiotics to obtain the Saccharomyces cerevisiae engineered bacteria K ⁇ -EGE2 with improved gene expression levels.
  • strain K ⁇ -EGE2 The schematic diagram of the construction of strain K ⁇ -EGE2 is shown in FIG1 .
  • the engineered strain K ⁇ -EGE2 constructed in this example contains a QS-EGE-2 system consisting of promoter P vrg4 , ⁇ factor kmf ⁇ 1 , promoter P fus1 and transcription activator gal4 .
  • Example 3 Verification of the effect of ⁇ factor on the expression level of GFP gene
  • the GFP gene (GenBank accession number is CAK02784.1) was synthesized by Suzhou Genewise Biotechnology Co., Ltd., and PCR amplification was performed using the GFP gene as a template.
  • the PCR amplification primer sequences are as follows:
  • yeGFP-pfus1-F 5′-CTGAAAATCAAAATGTCTAAAGGTGAAG-3′;
  • yeGFP-R 5′-AATTACATGATTATTTGTACAATTCATC-3′.
  • the genomic DNA of Saccharomyces cerevisiae W303-1a was used as a template for PCR amplification to obtain the promoter P fus1 and the terminator T cyc1 .
  • the sequences of the PCR amplification primers are as follows:
  • CYC1T-EGFP-1-F 5′-CAAATAATCATGTAATTAGTTATG-3′,
  • P fus1 , GFP gene and T cyc1 were subjected to fusion PCR at a molar ratio of 1:3:1 to obtain the fusion PCR product P vrg4 -kmf ⁇ 1-T cyc1 ;
  • P fus1 -GFP-T cyc1 was ligated between the HindIII and XbaI restriction sites of plasmid pRS305 to obtain the recombinant vector pRS305-P fus1 -GFP-T cyc1 ;
  • the recombinant vector pRS305-P fus1 -GFP-T cyc1 was linearized with endonuclease BspTI and transformed into strain VRG4p-K ⁇ , and screened with leucine-deficient SC solid culture medium to obtain strain K ⁇ -FUS1p-GFP.
  • the specific method is: transfer the strain to be tested in equal amounts to YPD medium and culture it in a shaker at 200 rpm and 30°C. During the test, 200 ⁇ L of bacterial solution was taken, washed once with ddH 2 O, and then transferred to a 96-well plate. The GFP intensity was detected by a fluorescence microplate reader (PerkinElmer, 1420 Multilabel Counter). The excitation light was set to 485 nm, the absorption light was set to 535 nm, the detection time was 1 s, and the reading was the GFP intensity. The sample was then tested for OD 600 absorption in a common microplate reader, and the reading can represent the cell growth.
  • the expression intensity of the exogenous gene GFP in the engineered bacteria K ⁇ -FUS1p-GFP was significantly improved after the introduction of the ⁇ factor.
  • the genomic DNA of Saccharomyces cerevisiae W303-1a was used as a template for PCR amplification to obtain the promoter P gal1 and the terminator T cyc1 .
  • the sequences of the PCR amplification primers are as follows:
  • CYC1T-EGFP-2-F 5′-AATTGTACAAATAACCGGTCTTGCTAGATTC-3′,
  • P gal1 , GFP gene and T cyc1 were subjected to fusion PCR at a molar ratio of 1:3:1 to obtain a fusion PCR product P gal1 -gfp-T cyc1 ;
  • P gal1 -gfp-T cyc1 was connected between the BamHI and HindIII restriction sites of plasmid pRS305 to obtain a recombinant vector pRS305-P gal1 -gfp-T cyc1 ;
  • the recombinant vector pRS305-P gal1 -gfp-T cyc1 was linearized with endonuclease BspTI, and then respectively in K ⁇ -EGE2, and screened by leucine-deficient SC solid culture medium to obtain the engineered bacteria K ⁇ -EGE2-GFP.
  • the nucleotide sequence of the promoter P gal1 is shown in SEQ ID NO.9.
  • the plasmid pRS305-P gal1 -gfp-T cyc1 was directly transformed into Saccharomyces cerevisiae W303-1a to obtain the control engineered bacteria gal-GFP.
  • the specific method is as follows: equal amounts of engineered bacteria gal-GFP and engineered bacteria K ⁇ -EGE2-GFP were transferred to YPD medium, respectively, and cultured in a shaker at 200 rpm and 30°C. During the detection, 200 ⁇ L of bacterial solution was taken, washed once with ddH 2 O, and then transferred to a 96-well plate. The GFP intensity was detected by a fluorescence microplate reader (PerkinElmer, 1420 Multilabel Counter). The excitation light was set to 485 nm, the absorption light was set to 535 nm, the detection time was 1 s, and the reading was the GFP intensity. Subsequently, the sample was tested for OD 600 absorption in a common microplate reader (Tecan 2000), and the reading can characterize the cell growth.
  • a fluorescence microplate reader PerkinElmer, 1420 Multilabel Counter
  • the expression level of GFP by the engineered bacteria K ⁇ -EGE2-GFP containing the QS-EGE2 system composed of promoter P vrg4 , ⁇ factor kmf ⁇ 1, promoter P fus1 and transcription activator gal4 is 2.7 times that of the promoter P gal1 under the gal-GFP activation state.
  • Example 5 Effect of initial induction of ⁇ factor on the output of the QS-EGE2 system
  • UP-VK-F 5′-TTCTGAAGATAGAACGCATTTTTG-3′;
  • UP-VK-R 5′-CATTACGCGTTTAGGCG-3′;
  • G418-VK-F 5′-GAAAAATATCACAGTTGACGAAAGAAGACACGTCGCCTAAACGCGTAATGATAACTTCGTATAATGTATGCTATACG-3′;
  • G418-VK-R 5′-GCAAATTAAAGCCTTCGAGCGTCCCAAAACCTTCTCAAGCAAGGTTTTCATTGATATAACTTCGTATAGCATACATTATAC-3′;
  • UP-VK-F 5′-GTTATATCAACTAGTGCTTGGAGTTGG-3′;
  • UP-VK-R 5′-GCAAATTAAAGCCTTCGAGC-3′.
  • the vector pYEP-CH with Cre recombinase was transformed into the engineered bacteria K ⁇ -EGE2-GFP, and screened on YPD solid medium with 200 ⁇ g/mL hygromycin antibiotics.
  • the obtained transformants were induced to express Cre recombinase by galactose, and the kanMX geneticin marker gene between the loxp sites was removed.
  • the ⁇ factor knockout expression cassette was then transformed into the transformants, and positive transformants were screened on a plate with 200 ⁇ g/mL G418 antibiotics to obtain the engineered bacteria EGE3-GFP.
  • the gene expression regulation system in the engineered bacteria EGE3-GFP was named QS-EGE3.
  • the schematic diagram of the construction of the strain EGE3-GFP is shown in Figure 4.
  • the expression level of GFP in the QS-EGE3 system without the ⁇ factor kmf ⁇ 1 is only 26% of that in the QS-EGE2 system of the engineered bacteria K ⁇ -EGE2-GFP, indicating that the ⁇ factor kmf ⁇ 1 sequence plays an important role in improving the expression level of exogenous genes in the QS-EGE2 system.
  • Plasmid pRS305-P gal1 -futBc-T cyc1 was constructed by inserting the promoter P gal1 , ⁇ -1,2-fucosyltransferase gene futBc and terminator T cyc1 into the vector plasmid pRS305.
  • the construction method can be found in the literature: Xu, M., et al., Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative ⁇ -1,2-fucosyltransferase from Bacillus cereus. Microbial Cell Factories, 2021.20(1): p.165.
  • Plasmid pRS305-P gal1 -fut3Bc-T cyc1 is constructed by inserting promoter P gal1 , ⁇ -1,3-fucosyltransferase gene fut3Bc (SEQ ID NO.2) and terminator T cyc1 into vector plasmid pRS305.
  • the construction method is the same as that of plasmid pRS305-P gal1 -futBc-T cyc1 , except that the fut3Bc gene is used to replace the futBc gene.
  • the PCR amplification primer sequences are as follows:
  • UP-gal-F 5′-GGGGAAACTTAAAGAAATTC-3′;
  • TEFt-his-F 5′-GTTCTTATGTAGACTGACAATAAAAAGATTCTTG-3′;
  • TEFt-TDH3p-R 5′-GATAATGACAGTATAGCGACCAGC-3′;
  • TDH-lac12-F 5′-TCGCTATACTGTCATTATCAATACTGCC-3′;
  • CYC1t-R 5′-AAGTATACGCAAATTAAAGCCTTCG-3′;
  • Down-gal-F 5′-GCTTTAATTTGCGTATACTTCTTTTTTTTACTTTG-3′;
  • Down-gal-R 5′-GTTTCAAGACGGCAATC-3′.
  • HIS3 and P tdh3 -lac12-T cyc1 were fused in a molar ratio of 1:1, and the resulting PCR product was further fused with the upstream and downstream homologous arms of the gal metabolic gene in a molar ratio of 1:3:1 to obtain the fusion PCR product gal1/7/10 ⁇ ::P tdh3 -lac12, which used HIS3 as a screening marker; gal1/7/10 ⁇ ::P tdh3 -lac12 was transformed into the engineered bacterium K ⁇ -EGE2, and screened through histidine-deficient SC solid culture medium to obtain the engineered bacterium K ⁇ -EGE4-L, which can absorb extracellular lactose.
  • Plasmid pRS305-P gal1 -futBc-T cyc1 and plasmid pRS305-P gal1 -fut3Bc-T cyc1 were transformed into the engineered bacteria K ⁇ -EGE4-L, and strains K ⁇ -EGE4-2FL and K ⁇ -EGE4-3FL were obtained by screening on SC solid medium lacking leucine.
  • the strain FL06 expressing the ⁇ -1,2-fucosyltransferase gene futBc and the 2'-FL synthesis pathway using the galactose-inducible promoter P gal was used as a control for the K ⁇ -EGE4-2FL strain.
  • the construction method of this strain can be found in the literature: Xu, M., et al., Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative ⁇ -1,2-fucosyltransferase from Bacillus cereus. Microbial Cell Factories, 2021.20(1): p.165.
  • the strain FL303 expressing the 3'-FL synthesis pathway with the galactose-inducible promoter P gal was used as a control for the K ⁇ -EGE4-3FL strain.
  • the construction method of this strain was the same as that of the strain FL06, except that the ⁇ -1,2-fucosyltransferase gene futBc was replaced by the ⁇ -1,3-fucosyltransferase gene fut3Bc (SEQ ID NO.2).
  • strain K ⁇ -EGE4-2FL and control strain FL06 was inoculated into 5 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate), and cultured at 30°C, 200 rpm for 24 h. Then, the culture was inoculated into 20 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate). The inoculation amount was adjusted so that the initial OD of the fermentation broth was about 0.2.
  • the strain K ⁇ -EGE4-2FL was supplemented with 30 g/L glucose and 4 g/L lactose
  • the control strain FL06 was supplemented with 30 g/L galactose and 4 g/L lactose.
  • the 2’-FL yield in the fermentation product is shown in Figure 6.
  • strain K ⁇ -EGE4-2FL and control strain FL303 was inoculated into 5 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate), and cultured at 30°C, 200 rpm for 24 h. Then, the culture was inoculated into 20 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate). The inoculation amount was adjusted so that the initial OD of the fermentation broth was about 0.2.
  • the strain K ⁇ -EGE4-3FL was supplemented with 30 g/L glucose and 2 g/L lactose
  • the control strain FL303 was supplemented with 30 g/L galactose and 2 g/L lactose.
  • the 3’-FL yield in the fermentation product is shown in Figure 7.
  • the 3'-FL production of strain K ⁇ -EGE4-3FL at 96 h was 2.36 g/L, which was 2.5 times the production of the control strain FL303 at 96 h, significantly improving the 3'-FL synthesis efficiency.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to saccharomyces cerevisiae engineering bacteria for improving a gene expression level and a construction method and application thereof. The saccharomyces cerevisiae W303-1a is used as an original strain. An extracellular protease coding gene bar1 and a galactose metabolic pathway inhibiting factor coding gene gal80 of the saccharomyces cerevisiae engineering bacteria are knocked out, and the saccharomyces cerevisiae engineering bacteria contain an α factor coding gene kmfα1 expressed by a promoter Pvrg4 and a transcriptional activator coding gene gal4 expressed by a promoter Pfus1. The saccharomyces cerevisiae engineering bacteria for improving a gene expression level provided in the present invention comprises a gene expression regulation and control system, used for regulating and controlling heterologous product pathway related enzymes comprising glycosyltransferase, thereby achieving the effect of improving the synthesis efficiency of a target product by enhancing the expression level of the heterologous product pathway related enzymes. When the strain is used for synthesizing 2-fucosyllactose and 3-fucosyllactose, the synthesis efficiency of 2-fucosyllactose and 3-fucosyllactose is improved significantly, and the strain has a good practical application value.

Description

一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用A brewer's yeast engineered bacterium for improving gene expression level and its construction method and application 技术领域Technical Field
本发明属于生物技术领域，具体涉及一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用。The invention belongs to the field of biotechnology, and in particular relates to an engineering bacterium of brewer's yeast with improved gene expression level, and a construction method and application thereof.
背景技术Background technique
酿酒酵母(Saccharomyces cerevisiae)，又称面包酵母，长期应用于酿酒、面包和馒头制作等，安全可靠，不产生毒素，是国际公认的食品安全级(Generally Regarded As Safe，GRAS)真核微生物；由于其菌体细胞富含营养，具很高的经济价值，酵母抽提物或酵母浸出物(Yeast Extract)不仅广泛用于微生物、动植物细胞培养，在制药、酿造及发酵食品中有着举足轻重的作用，而且也直接用于饲料及食品添加剂；由于酵母在工业生产中具有良好的发酵性能，在发酵过程中能够快速分裂，容易培养，对杂菌污染具有较强的抗性，遗传背景清晰，基因操作简单等优势，使其在基因工程技术中常被用于代谢工程改造的出发菌株；在新近推崇的合成生物学研究中，酿酒酵母因其特殊的代谢能力等特点已成为备受关注的底盘菌株，常用来合成异源高附加值产物。但异源代谢产物途径相关基因的组成型表达通常会导致细胞资源的过多消耗，抑制细胞生长，从而影响了目标产物的最终产量。Saccharomyces cerevisiae, also known as baker's yeast, has long been used in brewing, bread and steamed bun making, etc. It is safe and reliable, does not produce toxins, and is an internationally recognized food safety grade (Generally Considered As Safe, GRAS) eukaryotic microorganism. Because its bacterial cells are rich in nutrients and have high economic value, yeast extracts or yeast extracts (Yeast Extract) are not only widely used in microbial, animal and plant cell culture, but also play an important role in pharmaceutical, brewing and fermented foods, and are also directly used in feed and food additives. Yeast has good fermentation properties in industrial production, can divide quickly during the fermentation process, is easy to culture, has strong resistance to bacterial contamination, has a clear genetic background, and is simple to operate. Therefore, it is often used as a starting strain for metabolic engineering in genetic engineering technology. In the recently popular synthetic biology research, Saccharomyces cerevisiae has become a chassis strain that has attracted much attention due to its special metabolic capabilities and other characteristics, and is often used to synthesize heterologous high value-added products. However, the constitutive expression of genes related to the heterologous metabolite pathway usually leads to excessive consumption of cellular resources and inhibits cell growth, thus affecting the final yield of the target product.
为将细胞生长与产物合成解偶联，同时实现目标产物合成基因的高效表达，目前常用的诱导调控的方法如半乳糖诱导型启动子诱导异源途径基因表达，在细胞浓度达到一定值后添加诱导剂半乳糖，从而避免细胞生长初期过多的资源消耗。但如半乳糖等诱导物价格十分昂贵，工业化生产成本较高。In order to decouple cell growth from product synthesis and achieve efficient expression of target product synthesis genes, currently commonly used induction regulation methods such as galactose-inducible promoters induce heterologous pathway gene expression, and add inducer galactose after the cell concentration reaches a certain value, thereby avoiding excessive resource consumption in the early stage of cell growth. However, inducers such as galactose are very expensive, and the cost of industrial production is high.
酿酒酵母具有内源性的与细胞交配相关的信息素介导的转录调控系统，因此还可以以酿酒酵母内源性信息素响应途径为基础构建基因表达调控体系，实现外源基因的表达。但是使用该系统表达外源基因时，外源基因的表达水平会低于半乳糖代谢调控系统启动子Pgal1所驱动的基因表达水平，不适用于异源代谢产物合成。并且基于酿酒酵母内源性信息素Sα的群体感系统感应α因子的浓度阈值较低，在激活时会将细胞周期阻滞在G1期，严重抑制细胞生长，不利于制备异源代谢产物。因此进一步构建一种提高基因表达水平的酿酒酵母工程菌是十分必要的。Saccharomyces cerevisiae has an endogenous pheromone-mediated transcriptional regulation system related to cell mating. Therefore, a gene expression regulation system can be constructed based on the endogenous pheromone response pathway of Saccharomyces cerevisiae to achieve the expression of exogenous genes. However, when using this system to express exogenous genes, the expression level of the exogenous genes will be lower than the gene expression level driven by the promoter P gal1 of the galactose metabolism regulation system, and it is not suitable for the synthesis of heterologous metabolites. In addition, the concentration threshold of the quorum sensing system based on the endogenous pheromone Sα of Saccharomyces cerevisiae is low, and when activated, the cell cycle will be blocked in the G1 phase, severely inhibiting cell growth, which is not conducive to the preparation of heterologous metabolites. Therefore, it is very necessary to further construct an engineered strain of Saccharomyces cerevisiae that improves the gene expression level.
发明内容Summary of the invention
针对现有技术的不足，本发明提供了一种提高基因表达水平的酿酒酵母工程菌及其构建方法与应用。In view of the deficiencies of the prior art, the present invention provides an engineering yeast of Saccharomyces cerevisiae for improving the gene expression level and a construction method and application thereof.
本发明的技术方案如下：The technical solution of the present invention is as follows:
一种提高基因表达水平的酿酒酵母工程菌，是以酿酒酵母W303-1a为出发菌株，该酿酒酵母工程菌敲除了胞外蛋白酶编码基因bar1和半乳糖代谢途径抑制因子编码基因gal80， 同时含有以启动子Pvrg4表达的乳酸克鲁维酵母来源的Kα因子编码基因kmfα1和以启动子Pfus1表达的转录激活因子编码基因gal4。An engineered yeast strain for improving gene expression level is based on the yeast strain W303-1a, in which the extracellular protease encoding gene bar1 and the galactose metabolic pathway inhibitor encoding gene gal80 are knocked out. It also contains the Kα factor encoding gene kmfα1 from Kluyveromyces lactis expressed by the promoter P vrg4 and the transcription activator encoding gene gal4 expressed by the promoter P fus1 .
上述酿酒酵母工程菌的构建方法，包括步骤：以酿酒酵母W303-1a为出发菌株，敲除bar1基因，然后转化含有启动子Pvrg4和Kα因子编码基因kmfα1的重组载体pRS304-Pvrg4-kmfα1-Tcyc1，将gal4编码基因的原始启动子替换为Pfus1，再转化融合片段Pfus1-gal4，最后敲除gal80基因，经筛选、验证获得。The method for constructing the above-mentioned brewer's yeast engineering bacteria comprises the steps of: using brewer's yeast W303-1a as the starting strain, knocking out the bar1 gene, then transforming the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 containing the promoter P vrg4 and the Kα factor encoding gene kmfα1, replacing the original promoter of the gal4 encoding gene with P fus1 , then transforming the fusion fragment P fus1 -gal4, and finally knocking out the gal80 gene, and obtaining it through screening and verification.
根据本发明优选的，所述提高基因表达水平的酿酒酵母工程菌的构建方法，具体包括步骤如下：Preferably, according to the present invention, the method for constructing an engineered strain of Saccharomyces cerevisiae for improving the gene expression level comprises the following steps:
(1)以质粒pUMRI-A中两端带有loxp序列(CRE酶切割位点)的kanMX遗传霉素标记基因为模板，以Bar1-g418-UP-F和Bar1-g418-down-R为引物进行PCR扩增，得到bar1基因的敲除组件；然后将bar1基因的敲除组件转化至酿酒酵母菌株W303-1a，经筛选后得到敲除胞外蛋白酶Bar1编码基因的菌株Bar1Δ；(1) Using the kanMX geneticin marker gene with loxp sequences (CRE enzyme cleavage sites) at both ends in the plasmid pUMRI-A as a template, PCR amplification was performed with Bar1-g418-UP-F and Bar1-g418-down-R as primers to obtain the knockout component of the bar1 gene; then the knockout component of the bar1 gene was transformed into the Saccharomyces cerevisiae strain W303-1a, and after screening, the strain Bar1Δ in which the gene encoding the extracellular protease Bar1 was knocked out was obtained;
(2)人工合成密码子优化后的α因子编码基因kmfα1序列，然后进行PCR扩增，得到优化后的kmfα1序列；以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到启动子Pvrg4和终止子Tcyc1；将Pvrg4、优化后的kmfα1序列和Tcyc1进行融合PCR，再将融合PCR产物Pvrg4-kmfα1-Tcyc1连接到质粒pRS304上，得到重组载体pRS304-Pvrg4-kmfα1-Tcyc1；将重组载体pRS304-Pvrg4-kmfα1-Tcyc1转化至菌株Bar1Δ中，经筛选后得菌株VRG4p-Kα；(2) Artificially synthesizing the codon-optimized α-factor encoding gene kmfα1 sequence, and then performing PCR amplification to obtain the optimized kmfα1 sequence; performing PCR amplification using the genomic DNA of Saccharomyces cerevisiae W303-1a as a template to obtain the promoter P vrg4 and the terminator T cyc1 ; performing fusion PCR on P vrg4 , the optimized kmfα1 sequence and T cyc1 , and then connecting the fusion PCR product P vrg4 -kmfα1-T cyc1 to the plasmid pRS304 to obtain the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 ; transforming the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 into the strain Bar1Δ, and obtaining the strain VRG4p-Kα after screening;
(3)以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到带有启动子Pgal4下游同源臂序列的启动子Pfus1，以pUMRI-A质粒为模板进行PCR扩增，得到带有Pgal4上游同源臂序列的kanMX编码序列；将启动子Pfus1和kanMX序列进行融合PCR扩增，得融合PCR产物Pfus1-gal4片段；将Pfus1-gal4片段转化至菌株VRG4p-Kα，经筛选后得菌株Kα-EGE1；(3) Using the genomic DNA of Saccharomyces cerevisiae W303-1a as a template, PCR amplification was performed to obtain the promoter P fus1 with the downstream homology arm sequence of the promoter P gal4 , and PCR amplification was performed using the pUMRI-A plasmid as a template to obtain the kanMX coding sequence with the upstream homology arm sequence of P gal4 ; the promoter P fus1 and kanMX sequences were fused PCR amplified to obtain the fusion PCR product P fus1 -gal4 fragment; the P fus1 -gal4 fragment was transformed into the strain VRG4p-Kα, and the strain Kα-EGE1 was obtained after screening;
(4)以质粒pUMRI-A的kanMX遗传霉素标记基因为模板，以Gal80-knockout-F/R为引物进行PCR扩增，，得到gal80基因的敲除组件；然后将得到的gal80基因敲除组件转化至酿酒酵母菌株Kα-EGE1，经筛选后得到提高基因表达水平的酿酒酵母工程菌Kα-EGE2。(4) Using the kanMX geneticin marker gene of plasmid pUMRI-A as a template and Gal80-knockout-F/R as primers, PCR amplification was performed to obtain the knockout component of the gal80 gene; the obtained gal80 gene knockout component was then transformed into the cerevisiae Saccharomyces cerevisiae strain Kα-EGE1, and after screening, the cerevisiae engineered strain Kα-EGE2 with improved gene expression level was obtained.
根据本发明优选的，步骤(1)中，所述Bar1-g418-UP-F带有bar1上游50bp同源臂，Bar1-g418-down-R带有bar1下游50bp同源臂，具体序列如下：Preferably, according to the present invention, in step (1), the Bar1-g418-UP-F carries a 50 bp homology arm upstream of bar1, and the Bar1-g418-down-R carries a 50 bp homology arm downstream of bar1, and the specific sequences are as follows:
Bar1-g418-UP-F:5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′，Bar1-g418-UP-F: 5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′,
Bar1-g418-down-R:5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′。Bar1-g418-down-R: 5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′.
根据本发明优选的，步骤(1)中，所述loxp的序列如下： Preferably according to the present invention, in step (1), the sequence of loxP is as follows:
Loxp：5'-ATAACTTCGTATAGCATACATTATACGAAGTTAT-3'。Loxp: 5′-ATAACTTCGTATAGCATACATTATACGAAGTTAT-3′.
根据本发明优选的，步骤(2)中，所述α因子来自于克鲁维酵母，核苷酸序列如SEQ ID NO.1所示，PCR扩增引物序列如下：Preferably, in step (2), the α factor is from Kluyveromyces, the nucleotide sequence is shown in SEQ ID NO.1, and the PCR amplification primer sequence is as follows:
KMFa1-F:5′-ATGAAATTCTCTACTATATTAG-3′，KMFa1-F: 5′-ATGAAATTCTCTACTATATTAG-3′,
KMFa1-R:5′-ATTACATGATCAGAAAATTGGTTGGCC-3′。KMFa1-R: 5′-ATTACATGATCAGAAAATTGGTTGGCC-3′.
根据本发明优选的，步骤(2)中，所述启动子Pvrg4的PCR扩增引物序列如下：Preferably, according to the present invention, in step (2), the PCR amplification primer sequence of the promoter P vrg4 is as follows:
304-BamHI-VRG4p-F:5′-CGCTCTAGAACTAGTGGATCCCAAACAACAATTTCAACAG-3′，304-BamHI-VRG4p-F:5′-CGCTCTAGAACTAGTGGATCCCAAACAACAATTTCAACAG-3′,
VRG4p-mfa1-R:5′-TATAGTAGAGAATTTCATTCGGGCGAAAGATACTG-3′；VRG4p-mfa1-R:5′-TATAGTAGAGAATTTCATTCGGGCGAAAGATACTG-3′;
所述终止子Tcyc1的PCR引物序列如下：The PCR primer sequence of the terminator T cyc1 is as follows:
CYC1t-kmfa1-F:5′-CAATTTTCTGATCATGTAATTAGTTATG-3′；CYC1t-kmfa1-F:5′-CAATTTTCTGATCATGTAATTAGTTATG-3′;
304-XhoI-CYC1t-R:5′-GTACCGGGCCCCCCCTCGAGGCAAATTAAAGCCTTCG-3′。304-XhoI-CYC1t-R:5′-GTACCGGGCCCCCCCTCGAGGCAAATTAAAGCCTTCG-3′.
根据本发明优选的，步骤(3)中，所述带有启动子Pgal4下游同源臂的启动子Pfus1的PCR引物序列如下：Preferably, according to the present invention, in step (3), the PCR primer sequence of the promoter P fus1 with the downstream homology arm of the promoter P gal4 is as follows:
Fus1-F:5′-ATCAACAACAGGGTCAGC-3′；Fus1-F: 5′-ATCAACAACAGGGTCAGC-3′;
fus1-down-pgal4-R:5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′；fus1-down-pGal4-R:5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′;
所述带有启动子Pgal4上游同源臂的kanMX遗传霉素标记基因的PCR扩增引物序列如下：The PCR amplification primer sequence of the kanMX geneticin marker gene with the upstream homology arm of the promoter P gal4 is as follows:
UP-Pgal4-G418-F:5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′，UP-Pgal4-G418-F: 5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′,
G418-fus-R:5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′。G418-fus-R: 5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′.
根据本发明优选的，步骤(3)中，所述融合PCR中启动子Pfus1和转录激活因子gal4的摩尔比为1:1。Preferably according to the present invention, in step (3), the molar ratio of the promoter P fus1 and the transcription activator gal4 in the fusion PCR is 1:1.
根据本发明优选的，步骤(4)中，所述Gal80-knockout-F带有gal80上游50bp同源臂，Gal80-knockout-R带有gal80下游50bp同源臂，具体序列如下：According to the preferred embodiment of the present invention, in step (4), the Gal80-knockout-F carries a 50 bp homology arm upstream of gal80, and the Gal80-knockout-R carries a 50 bp homology arm downstream of gal80, and the specific sequences are as follows:
Gal80-knockout-F:5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′；Gal80-knockout-F: 5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′;
Gal80-knockout-R:5′-TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′。Gal80-knockout-R: 5′-TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′.
上述提高基因表达水平的酿酒酵母工程菌在构建表达外源基因的基因工程菌中的应用。 The application of the above-mentioned brewer's yeast engineering bacteria with improved gene expression level in constructing genetic engineering bacteria expressing foreign genes.
根据本发明优选的，所述表达外源基因的基因工程菌为含有外源基因或含该外源基因的载体的菌株，所述菌株的基因组中整合了所述外源基因。Preferably according to the present invention, the genetically engineered bacteria expressing the exogenous gene is a strain containing the exogenous gene or a vector containing the exogenous gene, and the exogenous gene is integrated into the genome of the strain.
根据本发明优选的，所述外源基因为工业、饲料或食品领域中用到的蛋白的编码序列。Preferably according to the present invention, the exogenous gene is a coding sequence of a protein used in the field of industry, feed or food.
进一步优选的，所述外源基因为酶的编码序列，所述酶为糖基转移酶。Further preferably, the exogenous gene is a coding sequence of an enzyme, and the enzyme is a glycosyltransferase.
最优选的，所述外源基因为α-1,3-岩藻糖基转移酶基因或α-1,2-岩藻糖基转移酶基因。Most preferably, the exogenous gene is an α-1,3-fucosyltransferase gene or an α-1,2-fucosyltransferase gene.
一株高产3-岩藻糖基乳糖的基因工程菌，所述基因工程菌同时表达乳糖透性酶、GDP-甘露糖脱氢酶、GDP-岩藻糖合成酶和α-1,3-岩藻糖基转移酶。A genetically engineered bacterium with high yield of 3-fucosyllactose, wherein the genetically engineered bacterium simultaneously expresses lactose permease, GDP-mannose dehydrogenase, GDP-fucose synthase and alpha-1,3-fucosyltransferase.
根据本发明优选的，所述基因工程菌为重组的酿酒酵母，所述酿酒酵母为酿酒酵母W303-1a；所述酿酒酵母W303-1a的基因型为MATa ade2-1 can1-100 ura3-1 leu2-3,112 his3-11,15。Preferably, according to the present invention, the genetically engineered bacteria is a recombinant Saccharomyces cerevisiae, and the Saccharomyces cerevisiae is Saccharomyces cerevisiae W303-1a; the genotype of the Saccharomyces cerevisiae W303-1a is MATa ade2-1 can1-100 ura3-1 leu2-3,112 his3-11,15.
根据本发明优选的，所述乳糖透性酶为来自克鲁维斯酵母的乳糖透性酶，其编码基因为Lac12，Genbank登录号为X06997.1。Preferably according to the present invention, the lactose permease is a lactose permease from Kluyveromyces cerevisiae, the encoding gene of which is Lac12 and the Genbank accession number is X06997.1.
根据本发明优选的，所述GDP-甘露糖脱氢酶为来自大肠杆菌K12的GDP-甘露糖脱氢酶，其编码基因为Gmd，Genbank登录号为WP_182915037.1。Preferably according to the present invention, the GDP-mannose dehydrogenase is GDP-mannose dehydrogenase from Escherichia coli K12, whose encoding gene is Gmd and whose Genbank accession number is WP_182915037.1.
根据本发明优选的，所述GDP-岩藻糖合成酶为来自大肠杆菌K12的GDP-岩藻糖合成酶，其编码基因为WcaG，Genbank登录号为WP_000043654.1。Preferably according to the present invention, the GDP-fucose synthase is the GDP-fucose synthase from Escherichia coli K12, the encoding gene of which is WcaG, and the Genbank accession number is WP_000043654.1.
本发明的技术特点：The technical features of the present invention are as follows:
1、本发明将启动子Pvrg4、α因子kmfα1、启动子Pfus1和转录激活因子gal4构成QS-EGE2系统，然后将该系统构建在敲除了胞外蛋白酶编码基因bar1和转录抑制因子编码基因gal80的酿酒酵母中。其中，在酿酒酵母中以弱启动子Pvrg4表达克鲁维酵母来源的Kα因子，明显降低了酿酒酵母α信息素调控系统激活时对细胞生长造成的抑制，利用这一激活的系统中转录水平上调较高的Pfus1驱动半乳糖代谢途径转录激活因子gal4的表达，进而利用gal4进一步激活启动子Pgal所表达的目标基因，取得了可明显提高基因表达水平的效果。敲除bar1可防止分泌至胞外的α因子被降解，而敲除gal80可以解除半乳糖代谢途径的抑制作用，进一步放大该系统的输出水平。1. The present invention forms a QS-EGE2 system with promoter P vrg4 , α factor kmfα1, promoter P fus1 and transcription activator gal4, and then constructs the system in Saccharomyces cerevisiae in which the extracellular protease encoding gene bar1 and the transcription repressor encoding gene gal80 are knocked out. In Saccharomyces cerevisiae, the Kα factor derived from Kluyveromyces is expressed with the weak promoter P vrg4 , which significantly reduces the inhibition of cell growth caused by the activation of the Saccharomyces cerevisiae α pheromone regulatory system. The P fus1 with a higher transcription level in the activated system is used to drive the expression of the transcription activator gal4 of the galactose metabolic pathway, and then gal4 is used to further activate the target gene expressed by the promoter P gal , thereby achieving the effect of significantly improving the gene expression level. Knocking out bar1 can prevent the degradation of the α factor secreted to the extracellular space, and knocking out gal80 can relieve the inhibitory effect of the galactose metabolic pathway, further amplifying the output level of the system.
2、本发明在酿酒酵母中同时表达了乳糖透性酶、GDP-甘露糖脱氢酶、GDP-岩藻糖合成酶和α-1,3-岩藻糖基转移酶，构建了新的基因工程菌，由于α-1,3-岩藻糖基转移酶Fut3Bc为优化过的密码子，合成3-FL的效率更高，且更加适合在酿酒酵母中表达，因此在使用该工程菌以乳糖和半乳糖为底物发酵生产3-FL时，极大地提高了3-FL的产量，产量可达0.93g/L，是已报道的常用合成3-FL的α-1,3-FT FutA菌株的5.4倍，为3-FL的工业化合成提供了重要参考和指导。2. The present invention simultaneously expresses lactose permease, GDP-mannose dehydrogenase, GDP-fucose synthase and α-1,3-fucosyltransferase in Saccharomyces cerevisiae, and constructs a new genetically engineered bacterium. Since the α-1,3-fucosyltransferase Fut3Bc is an optimized codon, the efficiency of synthesizing 3-FL is higher and it is more suitable for expression in Saccharomyces cerevisiae. Therefore, when the engineered bacterium is used to ferment and produce 3-FL with lactose and galactose as substrates, the yield of 3-FL is greatly improved, and the yield can reach 0.93 g/L, which is 5.4 times that of the commonly used α-1,3-FT FutA strain for synthesizing 3-FL that has been reported, providing important reference and guidance for the industrial synthesis of 3-FL.
本发明的有益效果：Beneficial effects of the present invention:
1、本发明以酿酒酵母内源性启动子Pfus1和转录激活因子gal4序列构成的信息素感应系统为基础，通过异源信息素α因子kmfα1的表达结合转录信号放大，得到了由启动子Pvrg4、 α因子kmfα1、启动子Pfus1和转录激活因子gal4构成的QS-EGE2系统。该系统可以实现外源基因的高水平表达。并且在外源基因高效表达的基础上，避免了酿酒酵母内源性α因子对细胞生长的抑制。1. The present invention is based on the pheromone sensing system composed of the endogenous promoter P fus1 of Saccharomyces cerevisiae and the transcription activator gal4 sequence. By combining the expression of the heterologous pheromone α factor kmfα1 with the amplification of the transcription signal, the promoter P vrg4 , The QS-EGE2 system consists of the α factor kmfα1, the promoter P fus1 and the transcription activator gal4. This system can achieve high-level expression of exogenous genes. And on the basis of efficient expression of exogenous genes, it avoids the inhibition of cell growth by the endogenous α factor of Saccharomyces cerevisiae.
2、本发明提供的提高基因表达水平的酿酒酵母工程菌中含有基因表达调控系统(QS-EGE2系统)，可用于调控包括糖基转移酶在内的异源产物途径相关酶，可通过增强其表达水平进而取得提高目标产物合成效率的效果。与酿酒酵母合成异源产物时常用的半乳糖诱导型启动子相比，本发明提供的QS-EGE2系统不需要额外添加半乳糖诱导基因的表达，在成本低廉的葡萄糖碳源下即可实现基因的高效表达，且基因的表达水平为半乳糖诱导型启动子Pgal1的2.7倍。利用本发明提供的提高基因表达水平的酿酒酵母工程菌进行2-岩藻糖基乳糖和3-岩藻糖基乳糖的合成时，明显提高了2-岩藻糖基乳糖和3-岩藻糖基乳糖的合成效率，证实了本发明的工程菌和QS-EGE2系统具有良好的实际应用价值。2. The saccharomyces cerevisiae engineered bacteria provided by the present invention that improve the gene expression level contains a gene expression regulation system (QS-EGE2 system), which can be used to regulate heterologous product pathway-related enzymes including glycosyltransferases, and can enhance their expression levels to thereby improve the efficiency of target product synthesis. Compared with the galactose-inducible promoter commonly used in saccharomyces cerevisiae to synthesize heterologous products, the QS-EGE2 system provided by the present invention does not require additional galactose-induced gene expression, and can achieve efficient gene expression under a low-cost glucose carbon source, and the gene expression level is 2.7 times that of the galactose-inducible promoter P gal1 . When the saccharomyces cerevisiae engineered bacteria that improve the gene expression level provided by the present invention are used to synthesize 2-fucosyllactose and 3-fucosyllactose, the synthesis efficiency of 2-fucosyllactose and 3-fucosyllactose is significantly improved, confirming that the engineered bacteria and QS-EGE2 system of the present invention have good practical application value.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为菌株Kα-EGE2的构建示意图。FIG1 is a schematic diagram of the construction of strain Kα-EGE2.
图2为工程菌Kα-FUS1p-GFP中基因表达调控系统强度图。FIG. 2 is a diagram showing the strength of the gene expression regulation system in the engineered bacteria Kα-FUS1p-GFP.
图3为工程菌Kα-EGE2-GFP中QS-EGE2系统强度图。FIG. 3 is a diagram showing the intensity of the QS-EGE2 system in the engineered bacteria Kα-EGE2-GFP.
图中：左图为Kα-EGE2-GFP和仅以半乳糖诱导型启动子表达GFP的菌株gal-GFP分别在葡萄糖碳源和半乳糖碳源下的生长曲线，右图为Kα-EGE2-GFP和半乳糖诱导下的菌株gal-GFP中的GFP表达强度。In the figure: the left figure shows the growth curves of Kα-EGE2-GFP and the strain gal-GFP expressing GFP only with a galactose-inducible promoter under glucose carbon source and galactose carbon source respectively; the right figure shows the GFP expression intensity in the strain gal-GFP under Kα-EGE2-GFP and galactose induction.
图4为菌株Kα-EGE3-GFP菌株构建示意图。FIG. 4 is a schematic diagram of the construction of strain Kα-EGE3-GFP.
图5为工程菌EGE3-GFP中QS-EGE3系统强度图。FIG. 5 is a diagram showing the intensity of the QS-EGE3 system in the engineered bacteria EGE3-GFP.
图中：左图为葡萄糖培养下的Kα-EGE2-GFP和Kα-EGE3-GFP生长曲线，右图葡萄糖培养下的Kα-EGE2-GFP和Kα-EGE3-GFP中GFP表达强度。In the figure: the left figure shows the growth curves of Kα-EGE2-GFP and Kα-EGE3-GFP under glucose culture, and the right figure shows the GFP expression intensity in Kα-EGE2-GFP and Kα-EGE3-GFP under glucose culture.
图6为菌株Kα-EGE4-2FL和对照菌株FL06发酵产物中的2’-FL产量图。FIG6 is a graph showing the 2′-FL yield in the fermentation products of strain Kα-EGE4-2FL and control strain FL06.
图中：左图为葡萄糖培养下的Kα-EGE4-2FL和半乳糖培养下的对照菌株FL06生长曲线，右图为葡萄糖培养下的Kα-EGE4-2FL和半乳糖培养下的对照菌株FL06中2’-FL产量。In the figure: the left figure shows the growth curves of Kα-EGE4-2FL cultured in glucose and the control strain FL06 cultured in galactose, and the right figure shows the 2’-FL yield in Kα-EGE4-2FL cultured in glucose and the control strain FL06 cultured in galactose.
图7为菌株Kα-EGE4-2FL和对照菌株FL303发酵产物中的3’-FL产量图。FIG. 7 is a graph showing the 3′-FL yield in the fermentation products of strain Kα-EGE4-2FL and control strain FL303.
图中：左图为葡萄糖培养下的Kα-EGE4-3FL和半乳糖培养下的对照菌株FL303生长曲线，右图为葡萄糖培养下的Kα-EGE4-3FL和半乳糖培养下的对照菌株FL303中3-FL产量。In the figure: the left figure shows the growth curves of Kα-EGE4-3FL cultured in glucose and the control strain FL303 cultured in galactose, and the right figure shows the 3-FL production in Kα-EGE4-3FL cultured in glucose and the control strain FL303 cultured in galactose.
具体实施方式Detailed ways
下面结合实施例和附图对本发明的技术方案作进一步说明，但是本发明的保护范围并不仅限于此。实施例中涉及的试剂及药品，若无特殊说明，均为普通市售产品；实施例中涉及的实验操作，若无特殊说明，均为本领域常规操作。The technical scheme of the present invention is further described below in conjunction with the examples and drawings, but the protection scope of the present invention is not limited thereto. The reagents and drugs involved in the examples are all common commercially available products unless otherwise specified; the experimental operations involved in the examples are all conventional operations in the art unless otherwise specified.
将克鲁维酵母来源的α因子编码基因进行酿酒酵母密码子优化后，在金唯智公司合成相应编码基因序列，得到α因子kmfα1序列； After optimizing the codons of Saccharomyces cerevisiae for the α-factor encoding gene from Kluyveromyces, the corresponding encoding gene sequence was synthesized at Genewise to obtain the α-factor kmfα1 sequence;
本发明中使用的酿酒酵母W303-1a为普通市售菌种，可从微生物保藏中心或菌种销售公司购得。The Saccharomyces cerevisiae W303-1a used in the present invention is a common commercial strain, which can be purchased from a microbial collection center or a strain sales company.
实施例1：胞外蛋白酶Bar1编码基因的敲除Example 1: Knockout of the gene encoding the extracellular protease Bar1
1、以质粒pUMRI-A中两端带有loxp序列的kanMX遗传霉素标记基因为模板，以带有bar1上游50bp同源臂的Bar1-g418-UP-F和带有bar1下游50bp同源臂的Bar1-g418-down-R为引物进行PCR扩增，得到bar1基因的敲除组件(SEQ ID NO.6)，所述引物具体序列如下：1. Using the kanMX geneticin marker gene with loxp sequences at both ends in plasmid pUMRI-A as a template, PCR amplification was performed using primers Bar1-g418-UP-F with a 50bp homology arm upstream of bar1 and Bar1-g418-down-R with a 50bp homology arm downstream of bar1 to obtain the knockout component of the bar1 gene (SEQ ID NO.6). The specific sequences of the primers are as follows:
Bar1-g418-UP-F:5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′，Bar1-g418-UP-F: 5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′,
Bar1-g418-down-R:5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′；Bar1-g418-down-R: 5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′;
PCR扩增体系：使用购自Vazyme的高保真DNA聚合酶Phanta Super-Fidelity DNA Polymerase，PCR扩增体系按照该试剂盒说明书配制。PCR amplification system: Use high-fidelity DNA polymerase Phanta Super-Fidelity DNA Polymerase purchased from Vazyme, and the PCR amplification system is prepared according to the instructions of the kit.
PCR扩增程序：预变性95℃3min，变性95℃15s，复性55℃15s，延伸72℃1min/kb，30个循环，后延伸72℃5min，12℃保存。PCR amplification program: pre-denaturation at 95°C for 3 min, denaturation at 95°C for 15 s, annealing at 55°C for 15 s, extension at 72°C for 1 min/kb, 30 cycles, post-extension at 72°C for 5 min, and storage at 12°C.
2、将bar1基因的敲除组件转化至酿酒酵母菌株W303-1a，在带有200μg/mL的G418抗生素的YPD固体培养基上筛选阳性转化子后，得敲除胞外蛋白酶Bar1编码基因的菌株Bar1Δ。2. The knockout component of the bar1 gene was transformed into the Saccharomyces cerevisiae strain W303-1a. After screening positive transformants on YPD solid medium with 200 μg/mL of G418 antibiotic, the strain Bar1Δ in which the gene encoding the extracellular protease Bar1 was knocked out was obtained.
所述YPD固体培养基的成分为：20g/L葡萄糖，20g/L蛋白胨，10g/L酵母提取物。The components of the YPD solid culture medium are: 20 g/L glucose, 20 g/L peptone, and 10 g/L yeast extract.
实施例2：工程菌Kα-EGE1的构建Example 2: Construction of engineered bacteria Kα-EGE1
1、将克鲁维酵母来源的α因子编码基因kmfα1序列进行酿酒酵母密码子优化，然后由苏州金唯智生物科技有限公司合成相应编码基因序列，以该序列为模板进行PCR扩增，得到优化后的kmfα1序列(SEQ ID NO.1)，PCR扩增引物序列如下：1. The α-factor encoding gene kmfα1 sequence from Kluyveromyces was codon-optimized for Saccharomyces cerevisiae, and then the corresponding encoding gene sequence was synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd. The sequence was used as a template for PCR amplification to obtain the optimized kmfα1 sequence (SEQ ID NO.1). The PCR amplification primer sequences are as follows:
KMFa1-F:5′-ATGAAATTCTCTACTATATTAG-3′，KMFa1-F: 5′-ATGAAATTCTCTACTATATTAG-3′,
KMFa1-R:5′-ATTACATGATCAGAAAATTGGTTGGCC-3′。KMFa1-R: 5′-ATTACATGATCAGAAAATTGGTTGGCC-3′.
以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到启动子Pvrg4和终止子Tcyc1，PCR扩增引物序列如下：The genomic DNA of Saccharomyces cerevisiae W303-1a was used as a template for PCR amplification to obtain the promoter P vrg4 and the terminator T cyc1 . The sequences of the PCR amplification primers are as follows:
304-BamHI-VRG4p-F:5′-CGCTCTAGAACTAGTGGATCCCAAACAACAATTTCAACAG-3′，304-BamHI-VRG4p-F:5′-CGCTCTAGAACTAGT GGATCC CAAACAACAATTTCAACAG-3′,
VRG4p-mfa1-R:5′-TATAGTAGAGAATTTCATTCGGGCGAAAGATACTG-3′；VRG4p-mfa1-R:5′-TATAGTAGAGAATTTCATTCGGGCGAAAGATACTG-3′;
CYC1t-kmfa1-F:5′-CAATTTTCTGATCATGTAATTAGTTATG-3′；CYC1t-kmfa1-F:5′-CAATTTTCTGATCATGTAATTAGTTATG-3′;
304-XhoI-CYC1t-R:5′-GTACCGGGCCCCCCCTCGAGGCAAATTAAAGCCTTCG-3′。304-XhoI-CYC1t-R:5′-GTACCGGGCCCCCCCTCGAGGCAAATTAAAGCCTTCG-3′.
将Pvrg4、优化后的kmfα1序列和Tcyc1按照1：3：1的摩尔比进行融合PCR，得融合 PCR产物Pvrg4-kmfα1-Tcyc1；将Pvrg4-kmfα1-Tcyc1通过T5外切酶连接的方法连接到质粒pRS304的XhoI和BamHI位点之间，得到重组载体pRS304-Pvrg4-kmfα1-Tcyc1；将重组载体pRS304-Pvrg4-kmfα1-Tcyc1以内切酶Bsu36I线性化后，转化至菌株Bar1Δ中，通过色氨酸缺陷的SC固体培养基筛选，得菌株VRG4p-Kα。P vrg4 , the optimized kmfα1 sequence and T cyc1 were fused by PCR at a molar ratio of 1:3:1 to obtain the fusion PCR product P vrg4 -kmfα1-T cyc1 ; P vrg4 -kmfα1-T cyc1 was ligated between the XhoI and BamHI sites of plasmid pRS304 by T5 exonuclease ligation to obtain the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 ; the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 was linearized with endonuclease Bsu36I, and then transformed into the strain Bar1Δ, and screened by tryptophan-deficient SC solid culture medium to obtain the strain VRG4p-Kα.
所述融合PCR采用VazymePhanta Super-Fidelity DNA Polymerase试剂盒完成，融合PCR体系按照该试剂盒说明书配制。The fusion PCR was completed using the VazymePhanta Super-Fidelity DNA Polymerase Kit, and the fusion PCR system was prepared according to the instructions of the kit.
所述启动子Pvrg4的核苷酸序列如SEQ ID NO.3所示，所述终止子Tcyc1的核苷酸序列如SEQ ID NO.5所示。The nucleotide sequence of the promoter P vrg4 is shown in SEQ ID NO.3, and the nucleotide sequence of the terminator T cyc1 is shown in SEQ ID NO.5.
2、以酿酒酵母W303-1a基因组DNA为模板，扩增得到带有启动子Pgal4下游同源臂的启动子Pfus1片段；以质粒pUMRI-A为模板，扩增得到带有启动子Pgal4上游同源臂的kanMX遗传霉素标记基因，PCR引物序列如下：2. Using the genomic DNA of Saccharomyces cerevisiae W303-1a as a template, the promoter P fus1 fragment with the downstream homology arm of the promoter P gal4 was amplified; using the plasmid pUMRI-A as a template, the kanMX geneticin marker gene with the upstream homology arm of the promoter P gal4 was amplified. The PCR primer sequences are as follows:
Fus1-F:5′-ATCAACAACAGGGTCAGC-3′；Fus1-F: 5′-ATCAACAACAGGGTCAGC-3′;
fus1-down-pgal4-R:5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′；fus1-down-pGal4-R:5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′;
UP-Pgal4-G418-F:5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′，UP-Pgal4-G418-F: 5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′,
G418-fus-R:5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′。G418-fus-R: 5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′.
将带有Cre重组酶的载体YEp-CH转化至工程菌VRG4p-Kα中，在带有200μg/mL的hygromycin抗生素的YPD固体培养基上进行筛选，所得到的转化子通过半乳糖诱导Cre重组酶表达，切除loxp位点之间的kanMX遗传霉素标记基因。将启动子Pfus1和kanMX序列按照1：1的摩尔比进行融合PCR，得融合PCR产物Pfus1-gal4片段；将Pfus1-gal4片段转化至菌株VRG4p-Kα，在带有200μg/mL的G418抗生素的YPD固体培养基上筛选阳性转化子后，得到菌株Kα-EGE1。The vector YEp-CH with Cre recombinase was transformed into the engineering bacteria VRG4p-Kα, and screened on YPD solid medium with 200μg/mL hygromycin antibiotics. The obtained transformants were induced by galactose to express Cre recombinase, and the kanMX geneticin marker gene between the loxp sites was removed. The promoter P fus1 and kanMX sequences were fused by PCR at a molar ratio of 1:1 to obtain the fusion PCR product P fus1 -gal4 fragment; the P fus1 -gal4 fragment was transformed into the strain VRG4p-Kα, and the positive transformants were screened on YPD solid medium with 200μg/mL G418 antibiotics to obtain the strain Kα-EGE1.
所述启动子Pfus1的核苷酸序列如SEQ ID NO.4所示；所述Pfus1-gal4片段的核苷酸序列如SEQ ID NO.7所示The nucleotide sequence of the promoter P fus1 is shown in SEQ ID NO.4; the nucleotide sequence of the P fus1 -gal4 fragment is shown in SEQ ID NO.7
所述带有Cre重组酶的载体的构建方法可参考文献：Li,H.,Shen,Y.,Wu,M.,Hou,J.,Jiao,C.,Li,Z.,Liu,X.,and Bao,X.(2016)Engineering a wild-type diploid Saccharomyces cerevisiae strain for second-generation bioethanol production,Bioresources and Bioprocessing 3,51。For the construction method of the vector carrying Cre recombinase, reference can be made to: Li, H., Shen, Y., Wu, M., Hou, J., Jiao, C., Li, Z., Liu, X., and Bao, X. (2016) Engineering a wild-type diploid Saccharomyces cerevisiae strain for second-generation bioethanol production, Bioresources and Bioprocessing 3, 51.
本步骤所得的工程菌Kα-EGE1中含有由启动子Pvrg4、α因子kmfα1和元件Pfus1-gal4构成的QS-EGE1系统。The engineered bacteria Kα-EGE1 obtained in this step contains the QS-EGE1 system composed of the promoter P vrg4 , the α factor kmfα1 and the element P fus1 -gal4 .
3、以pUMRI-A质粒为模板，以带有gal80上游50bp同源臂的Gal80-knockout-F和带有gal80下游50bp同源臂的Gal80-knockout-R为引物进行PCR扩增，得到gal80基因的敲 除组件(SEQ ID NO.8)，PCR扩增引物序列如下：3. Using pUMRI-A plasmid as template, PCR amplification was performed with Gal80-knockout-F with a 50 bp homology arm upstream of gal80 and Gal80-knockout-R with a 50 bp homology arm downstream of gal80 to obtain the knockout gene of gal80. Except for the component (SEQ ID NO.8), the PCR amplification primer sequences are as follows:
Gal80-knockout-F:5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′；Gal80-knockout-F: 5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′;
Gal80-knockout-R:5′-TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′。Gal80-knockout-R: 5′-TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′.
将带有Cre重组酶的载体YEp-CH转化至工程菌Kα-EGE1中，在带有200μg/mL的hygromycin抗生素的YPD固体培养基上进行筛选，所得到的转化子通过半乳糖诱导Cre重组酶表达，切除loxp位点之间的kanMX遗传霉素标记基因，然后将gal80基因的敲除组件转化至该菌株中，在带有200μg/mL的G418抗生素的平板上筛选阳性转化子，得到提高基因表达水平的酿酒酵母工程菌Kα-EGE2。The vector YEp-CH carrying the Cre recombinase was transformed into the engineered bacteria Kα-EGE1 and screened on a YPD solid culture medium containing 200 μg/mL of hygromycin antibiotics. The obtained transformants were induced to express the Cre recombinase by galactose, the kanMX geneticin marker gene between the loxp sites was removed, and then the knockout component of the gal80 gene was transformed into the strain. Positive transformants were screened on a plate containing 200 μg/mL of G418 antibiotics to obtain the Saccharomyces cerevisiae engineered bacteria Kα-EGE2 with improved gene expression levels.
菌株Kα-EGE2的构建示意图如图1所示，本实施例构建的工程菌Kα-EGE2中含有由启动子Pvrg4、α因子kmfα1、启动子Pfus1和转录激活因子gal4构成的QS-EGE-2系统。The schematic diagram of the construction of strain Kα-EGE2 is shown in FIG1 . The engineered strain Kα-EGE2 constructed in this example contains a QS-EGE-2 system consisting of promoter P vrg4 , α factor kmfα1 , promoter P fus1 and transcription activator gal4 .
本实施例中所述PCR扩增体系、PCR扩增程序、融合PCR体系和融合PCR程序同实施例1。The PCR amplification system, PCR amplification procedure, fusion PCR system and fusion PCR procedure described in this example are the same as those in Example 1.
实施例3：α因子提高GFP基因表达水平的验证Example 3: Verification of the effect of α factor on the expression level of GFP gene
1、由苏州金唯智生物科技有限公司合成GFP基因(GenBank登录号为CAK02784.1)，以GFP基因为模板进行PCR扩增，PCR扩增引物序列如下：1. The GFP gene (GenBank accession number is CAK02784.1) was synthesized by Suzhou Genewise Biotechnology Co., Ltd., and PCR amplification was performed using the GFP gene as a template. The PCR amplification primer sequences are as follows:
yeGFP-pfus1-F:5′-CTGAAAATCAAAATGTCTAAAGGTGAAG-3′；yeGFP-pfus1-F: 5′-CTGAAAATCAAAATGTCTAAAGGTGAAG-3′;
yeGFP-R:5′-AATTACATGATTATTTGTACAATTCATC-3′。yeGFP-R:5′-AATTACATGATTATTTGTACAATTCATC-3′.
以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到启动子Pfus1和终止子Tcyc1，PCR扩增引物序列如下：The genomic DNA of Saccharomyces cerevisiae W303-1a was used as a template for PCR amplification to obtain the promoter P fus1 and the terminator T cyc1 . The sequences of the PCR amplification primers are as follows:
305-XbaI-pFUS1-F:5′-CACCGCGGTGGCGGCCGCTCTAGAATCAACAACAGGGTC-3′；305-XbaI-pFUS1-F:5′-CACCGCGGTGGCGGCCGC TCTAGA ATCAACAACAGGGTC-3′;
pFUS1-yegfp-R:5′-TTTAGACATTTTGATTTTCAGAAACTTG-3′；pFUS1-yegfp-R:5′-TTTAGACATTTTGATTTTCAGAAACTTG-3′;
CYC1t-egfp-1-F:5′-CAAATAATCATGTAATTAGTTATG-3′，CYC1T-EGFP-1-F: 5′-CAAATAATCATGTAATTAGTTATG-3′,
305-HindIII-CYC1t-1-R:5′-GGTCGACGGTATCGATAAGCTTCTTCGAGCGTCCCAAAAC-3′。305-HindIII-CYC1t-1-R: 5′-GGTCGACGGTATCGAT AAGCTT CTTCGAGCGTCCCAAAAC-3′.
将Pfus1、GFP基因和Tcyc1按照1：3：1的摩尔比进行融合PCR，得融合PCR产物Pvrg4-kmfα1-Tcyc1；将Pfus1-GFP-Tcyc1连接到质粒pRS305的HindIII和XbaI酶切位点之间，得到重组载体pRS305-Pfus1-GFP-Tcyc1；将重组载体pRS305-Pfus1-GFP-Tcyc1以内切酶BspTI线性化后，转化至菌株VRG4p-Kα中，通过亮氨酸缺陷的SC固体培养基筛选，得菌株Kα-FUS1p-GFP。P fus1 , GFP gene and T cyc1 were subjected to fusion PCR at a molar ratio of 1:3:1 to obtain the fusion PCR product P vrg4 -kmfα1-T cyc1 ; P fus1 -GFP-T cyc1 was ligated between the HindIII and XbaI restriction sites of plasmid pRS305 to obtain the recombinant vector pRS305-P fus1 -GFP-T cyc1 ; the recombinant vector pRS305-P fus1 -GFP-T cyc1 was linearized with endonuclease BspTI and transformed into strain VRG4p-Kα, and screened with leucine-deficient SC solid culture medium to obtain strain Kα-FUS1p-GFP.
2、对菌株Kα-FUS1p-GFP进行系统输出强度测试，结果如图2所示。2. The system output intensity of strain Kα-FUS1p-GFP was tested, and the results are shown in Figure 2.
具体方法为：将待测菌株等量转接至YPD培养基中，摇床中200rpm，30℃培养。检 测时取200μL菌液，以ddH2O清洗一次后转移至96孔板中，以荧光酶标仪(PerkinElmer，1420Multilabel Counter)检测GFP强度，检测时设置激发光485nm，吸收光535nm，检测时长1s，读数为GFP强度。随后将样品在普通酶标仪中检测OD 600吸收，读数可表征细胞生长量。The specific method is: transfer the strain to be tested in equal amounts to YPD medium and culture it in a shaker at 200 rpm and 30°C. During the test, 200 μL of bacterial solution was taken, washed once with ddH 2 O, and then transferred to a 96-well plate. The GFP intensity was detected by a fluorescence microplate reader (PerkinElmer, 1420 Multilabel Counter). The excitation light was set to 485 nm, the absorption light was set to 535 nm, the detection time was 1 s, and the reading was the GFP intensity. The sample was then tested for OD 600 absorption in a common microplate reader, and the reading can represent the cell growth.
由图2可知，在引入α因子后的工程菌Kα-FUS1p-GFP中外源基因GFP的表达强度明显提高。As shown in FIG2 , the expression intensity of the exogenous gene GFP in the engineered bacteria Kα-FUS1p-GFP was significantly improved after the introduction of the α factor.
实施例4：GFP基因在工程菌Kα-EGE2中的表达Example 4: Expression of GFP gene in engineered bacteria Kα-EGE2
1、按照实施例3中的方法获得GFP基因。1. Obtain the GFP gene according to the method in Example 3.
以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到启动子Pgal1和终止子Tcyc1，PCR扩增引物序列如下：The genomic DNA of Saccharomyces cerevisiae W303-1a was used as a template for PCR amplification to obtain the promoter P gal1 and the terminator T cyc1 . The sequences of the PCR amplification primers are as follows:
305-BamHI-pGAL1-F:5′-CCGCTCTAGAACTAGTGGATCCCGGATTAGAAGCCGCCG-3′；305-BamHI-pGAL1-F:5′-CCGCTCTAGAACTAGT GGATCC CGGATTAGAAGCCGCCG-3′;
pGAL1-yegfp-R:5′-TTCACCTTTAGACATAATATTCCCTATAG-3′；pGAL1-yegfp-R:5′-TTCACCTTTAGACATAATATTCCCTATAG-3′;
CYC1t-egfp-2-F:5′-AATTGTACAAATAACCGGTCTTGCTAGATTC-3′，CYC1T-EGFP-2-F: 5′-AATTGTACAAATAACCGGTCTTGCTAGATTC-3′,
305-HindIII-CYC1t-2-R:5′-GGTCGACGGTATCGATAAGCTTCTTCGAGCGTCCCAAAAC-3′。305-HindIII-CYC1t-2-R: 5′-GGTCGACGGTATCGAT AAGCTT CTTCGAGCGTCCCAAAAC-3′.
将Pgal1、GFP基因和Tcyc1按照1：3：1的摩尔比进行融合PCR，得融合PCR产物Pgal1-gfp-Tcyc1；将Pgal1-gfp-Tcyc1连接到质粒pRS305的BamHI和HindIII酶切位点之间，得到重组载体pRS305-Pgal1-gfp-Tcyc1；将重组载体pRS305-Pgal1-gfp-Tcyc1以内切酶BspTI线性化后，分别Kα-EGE2中，通过亮氨酸缺陷的SC固体培养基筛选，得工程菌Kα-EGE2-GFP。所述启动子Pgal1的核苷酸序列如SEQ ID NO.9所示。P gal1 , GFP gene and T cyc1 were subjected to fusion PCR at a molar ratio of 1:3:1 to obtain a fusion PCR product P gal1 -gfp-T cyc1 ; P gal1 -gfp-T cyc1 was connected between the BamHI and HindIII restriction sites of plasmid pRS305 to obtain a recombinant vector pRS305-P gal1 -gfp-T cyc1 ; the recombinant vector pRS305-P gal1 -gfp-T cyc1 was linearized with endonuclease BspTI, and then respectively in Kα-EGE2, and screened by leucine-deficient SC solid culture medium to obtain the engineered bacteria Kα-EGE2-GFP. The nucleotide sequence of the promoter P gal1 is shown in SEQ ID NO.9.
将质粒pRS305-Pgal1-gfp-Tcyc1直接转化至酿酒酵母W303-1a中得到对照工程菌gal-GFP。The plasmid pRS305-P gal1 -gfp-T cyc1 was directly transformed into Saccharomyces cerevisiae W303-1a to obtain the control engineered bacteria gal-GFP.
2、对表达外源基因GFP的工程菌Kα-EGE2-GFP进行QS-EGE2系统输出强度测试，结果如图3所示。2. The QS-EGE2 system output intensity test was performed on the engineered bacteria Kα-EGE2-GFP expressing the exogenous gene GFP. The results are shown in Figure 3.
具体方法为：将等量的工程菌gal-GFP和工程菌Kα-EGE2-GFP分别转接至YPD培养基中，摇床中200rpm，30℃培养。检测时取200μL菌液，以ddH2O清洗一次后转移至96孔板中，以荧光酶标仪(PerkinElmer，1420Multilabel Counter)检测GFP强度，检测时设置激发光485nm，吸收光535nm，检测时长1s，读数为GFP强度。随后将样品在普通酶标仪(Tecan 2000)中检测OD 600吸收，读数可表征细胞生长量。The specific method is as follows: equal amounts of engineered bacteria gal-GFP and engineered bacteria Kα-EGE2-GFP were transferred to YPD medium, respectively, and cultured in a shaker at 200 rpm and 30°C. During the detection, 200 μL of bacterial solution was taken, washed once with ddH 2 O, and then transferred to a 96-well plate. The GFP intensity was detected by a fluorescence microplate reader (PerkinElmer, 1420 Multilabel Counter). The excitation light was set to 485 nm, the absorption light was set to 535 nm, the detection time was 1 s, and the reading was the GFP intensity. Subsequently, the sample was tested for OD 600 absorption in a common microplate reader (Tecan 2000), and the reading can characterize the cell growth.
由图3可知，含有由启动子Pvrg4、α因子kmfα1、启动子Pfus1和转录激活因子gal4构成的QS-EGE2系统的工程菌Kα-EGE2-GFP对GFP的表达水平是gal-GFP激活状态下启动子Pgal1的2.7倍。As shown in Figure 3, the expression level of GFP by the engineered bacteria Kα-EGE2-GFP containing the QS-EGE2 system composed of promoter P vrg4 , α factor kmfα1, promoter P fus1 and transcription activator gal4 is 2.7 times that of the promoter P gal1 under the gal-GFP activation state.
实施例5：α因子的起始诱导作用对QS-EGE2系统输出的影响Example 5: Effect of initial induction of α factor on the output of the QS-EGE2 system
1、以质粒pRS304为模板进行PCR扩增，分别得到Kα因子表达盒上下游同源臂，以质粒pUMRI-A为模板扩增kanMX遗传霉素标记基因，通过PCR融合，将以上三个片段连 接，得到α因子敲除表达盒，PCR扩增引物序列如下：1. Use plasmid pRS304 as template to perform PCR amplification to obtain the upstream and downstream homology arms of the Kα factor expression cassette, and use plasmid pUMRI-A as template to amplify the kanMX geneticin marker gene. Use PCR fusion to connect the above three fragments. Then, the α factor knockout expression cassette was obtained, and the PCR amplification primer sequences were as follows:
UP-VK-F:5′-TTCTGAAGATAGAACGCATTTTTG-3′；UP-VK-F: 5′-TTCTGAAGATAGAACGCATTTTTG-3′;
UP-VK-R:5′-CATTACGCGTTTAGGCG-3′；UP-VK-R: 5′-CATTACGCGTTTAGGCG-3′;
G418-VK-F:5′-GAAAAATATCACAGTTGACGAAAGAAGACACGTCGCCTAAACGCGTAATGATAACTTCGTATAATGTATGCTATACG-3′；G418-VK-F: 5′-GAAAAATATCACAGTTGACGAAAGAAGACACGTCGCCTAAACGCGTAATGATAACTTCGTATAATGTATGCTATACG-3′;
G418-VK-R:5′-GCAAATTAAAGCCTTCGAGCGTCCCAAAACCTTCTCAAGCAAGGTTTTCATTGATATAACTTCGTATAGCATACATTATAC-3′；G418-VK-R: 5′-GCAAATTAAAGCCTTCGAGCGTCCCAAAACCTTCTCAAGCAAGGTTTTCATTGATATAACTTCGTATAGCATACATTATAC-3′;
UP-VK-F:5′-GTTATATCAACTAGTGCTTGGAGTTGG-3′；UP-VK-F: 5′-GTTATATCAACTAGTGCTTGGAGTTGG-3′;
UP-VK-R:5′-GCAAATTAAAGCCTTCGAGC-3′。UP-VK-R: 5′-GCAAATTAAAGCCTTCGAGC-3′.
将带有Cre重组酶的载体pYEP-CH转化至工程菌Kα-EGE2-GFP中，在带有200μg/mL的hygromycin抗生素的YPD固体培养基上进行筛选，所得到的转化子通过半乳糖诱导Cre重组酶表达，切除loxp位点之间的kanMX遗传霉素标记基因，再向该转化子中转化α因子敲除表达盒，在带有200μg/mL的G418抗生素的平板上筛选阳性转化子，得工程菌EGE3-GFP。工程菌EGE3-GFP中的基因表达调控系统命名为QS-EGE3。菌株EGE3-GFP的构建示意图如图4所示。The vector pYEP-CH with Cre recombinase was transformed into the engineered bacteria Kα-EGE2-GFP, and screened on YPD solid medium with 200 μg/mL hygromycin antibiotics. The obtained transformants were induced to express Cre recombinase by galactose, and the kanMX geneticin marker gene between the loxp sites was removed. The α factor knockout expression cassette was then transformed into the transformants, and positive transformants were screened on a plate with 200 μg/mL G418 antibiotics to obtain the engineered bacteria EGE3-GFP. The gene expression regulation system in the engineered bacteria EGE3-GFP was named QS-EGE3. The schematic diagram of the construction of the strain EGE3-GFP is shown in Figure 4.
4、对工程菌EGE3-GFP进行QS-EGE3系统输出强度测试，结果如图5所示，测试方法同实施例4。4. The QS-EGE3 system output intensity test was performed on the engineered bacteria EGE3-GFP. The results are shown in FIG5 . The test method is the same as that in Example 4.
由图5可知，没有α因子kmfα1的QS-EGE3系统对GFP的表达水平仅为工程菌Kα-EGE2-GFP的QS-EGE2系统的26％，说明α因子kmfα1序列在QS-EGE2系统中起到了提高外源基因表达水平中的重要作用。As shown in Figure 5, the expression level of GFP in the QS-EGE3 system without the α factor kmfα1 is only 26% of that in the QS-EGE2 system of the engineered bacteria Kα-EGE2-GFP, indicating that the α factor kmfα1 sequence plays an important role in improving the expression level of exogenous genes in the QS-EGE2 system.
实施例6：利用工程菌Kα-EGE2制备2-岩藻糖基乳糖(2’-FL)和3-岩藻糖基乳糖(3’-FL)Example 6: Preparation of 2-fucosyllactose (2'-FL) and 3-fucosyllactose (3'-FL) using engineered bacteria Kα-EGE2
质粒pRS305-Pgal1-futBc-Tcyc1是将启动子Pgal1、α-1,2-岩藻糖基转移酶基因futBc和终止子Tcyc1插入载体质粒pRS305中构建得到，构建方法可参考文献：Xu,M.,et al.,Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1,2-fucosyltransferase from Bacillus cereus.Microbial Cell Factories,2021.20(1):p.165。Plasmid pRS305-P gal1 -futBc-T cyc1 was constructed by inserting the promoter P gal1 , α-1,2-fucosyltransferase gene futBc and terminator T cyc1 into the vector plasmid pRS305. The construction method can be found in the literature: Xu, M., et al., Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1,2-fucosyltransferase from Bacillus cereus. Microbial Cell Factories, 2021.20(1): p.165.
质粒pRS305-Pgal1-fut3Bc-Tcyc1是将启动子Pgal1、α-1,3-岩藻糖基转移酶基因fut3Bc(SEQ ID NO.2)和终止子Tcyc1插入载体质粒pRS305中构建得到，构建方法与质粒pRS305-Pgal1-futBc-Tcyc1的构建方法相同，不同之处在于使用fut3Bc基因替换了futBc基因。Plasmid pRS305-P gal1 -fut3Bc-T cyc1 is constructed by inserting promoter P gal1 , α-1,3-fucosyltransferase gene fut3Bc (SEQ ID NO.2) and terminator T cyc1 into vector plasmid pRS305. The construction method is the same as that of plasmid pRS305-P gal1 -futBc-T cyc1 , except that the fut3Bc gene is used to replace the futBc gene.
1、以酿酒酵母W303-1a基因组DNA为模板，扩增得到半乳糖代谢基因gal上下游同源臂以及启动子Ptdh3和终止子Tcyc1，以克鲁维酵母基因组DNA为模板，扩增得到乳糖透性酶Lac12编码基因，以质粒pRS303为模板，扩增得到HIS3筛选marker基因。 1. Using the genomic DNA of Saccharomyces cerevisiae W303-1a as a template, the upstream and downstream homologous arms of the galactose metabolism gene gal, the promoter P tdh3 and the terminator T cyc1 were amplified. Using the genomic DNA of Kluyveromyces cerevisiae as a template, the lactose permease Lac12 encoding gene was amplified. Using the plasmid pRS303 as a template, the HIS3 screening marker gene was amplified.
PCR扩增引物序列如下：The PCR amplification primer sequences are as follows:
UP-gal-F:5′-GGGGAAACTTAAAGAAATTC-3′；UP-gal-F: 5′-GGGGAAACTTAAAGAAATTC-3′;
UP-gal-his-R:5′-AGTGTACTAGAGTCAAGAGTCGTAGTGGAG-3′；UP-gal-his-R:5′-AGTGTACTAGAGTCAAGAGTCGTAGTGGAG-3′;
His-F:5′-ACGACTCTTGACTCTAGTACACTCTATATTTTTTTATG-3′；His-F: 5′-ACGACTCTTGACTCTAGTACACTCTATATTTTTTTATG-3′;
His-R:5′-TATTGTCAGTCTACATAAGAACACCTTTG-3′；His-R: 5′-TATTGTCAGTCTACATAAGAACACCTTTG-3′;
TEFt-his-F:5′-GTTCTTATGTAGACTGACAATAAAAAGATTCTTG-3′；TEFt-his-F: 5′-GTTCTTATGTAGACTGACAATAAAAAGATTCTTG-3′;
TEFt-TDH3p-R:5′-GATAATGACAGTATAGCGACCAGC-3′；TEFt-TDH3p-R:5′-GATAATGACAGTATAGCGACCAGC-3′;
TDH-lac12-F:5′-TCGCTATACTGTCATTATCAATACTGCC-3′；TDH-lac12-F: 5′-TCGCTATACTGTCATTATCAATACTGCC-3′;
CYC1t-R:5′-AAGTATACGCAAATTAAAGCCTTCG-3′；CYC1t-R: 5′-AAGTATACGCAAATTAAAGCCTTCG-3′;
Down-gal-F:5′-GCTTTAATTTGCGTATACTTCTTTTTTTTACTTTG-3′；Down-gal-F: 5′-GCTTTAATTTGCGTATACTTCTTTTTTTTACTTTG-3′;
Down-gal-R:5′-GTTTCAAGACGGCAATC-3′。Down-gal-R: 5′-GTTTCAAGACGGCAATC-3′.
首先将HIS3、Ptdh3-lac12-Tcyc1以1：1的摩尔比融合，所得到的PCR产物进一步与gal代谢基因上下游同源臂1：3：1摩尔比融合，得融合PCR产物gal1/7/10Δ::Ptdh3-lac12，该产物以HIS3为筛选标记；将gal1/7/10Δ::Ptdh3-lac12转化至工程菌Kα-EGE2中，通过组氨酸缺陷的SC固体培养基筛选，得工程菌Kα-EGE4-L，该菌株可吸收胞外的乳糖。First, HIS3 and P tdh3 -lac12-T cyc1 were fused in a molar ratio of 1:1, and the resulting PCR product was further fused with the upstream and downstream homologous arms of the gal metabolic gene in a molar ratio of 1:3:1 to obtain the fusion PCR product gal1/7/10Δ::P tdh3 -lac12, which used HIS3 as a screening marker; gal1/7/10Δ::P tdh3 -lac12 was transformed into the engineered bacterium Kα-EGE2, and screened through histidine-deficient SC solid culture medium to obtain the engineered bacterium Kα-EGE4-L, which can absorb extracellular lactose.
将质粒pRS305-Pgal1-futBc-Tcyc1和质粒pRS305-Pgal1-fut3Bc-Tcyc1分别转化至工程菌Kα-EGE4-L中，通过在缺少亮氨酸的SC固体培养基上进行筛选，分别得到菌株Kα-EGE4-2FL和Kα-EGE4-3FL。Plasmid pRS305-P gal1 -futBc-T cyc1 and plasmid pRS305-P gal1 -fut3Bc-T cyc1 were transformed into the engineered bacteria Kα-EGE4-L, and strains Kα-EGE4-2FL and Kα-EGE4-3FL were obtained by screening on SC solid medium lacking leucine.
2、以半乳糖诱导型启动子Pgal表达α-1,2-岩藻糖基转移酶基因futBc，2’-FL合成途径的菌株FL06作为Kα-EGE4-2FL菌株的对照，该菌株的构建方法可参考文献：Xu,M.,et al.,Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1,2-fucosyltransferase from Bacillus cereus.Microbial Cell Factories,2021.20(1):p.165。2. The strain FL06 expressing the α-1,2-fucosyltransferase gene futBc and the 2'-FL synthesis pathway using the galactose-inducible promoter P gal was used as a control for the Kα-EGE4-2FL strain. The construction method of this strain can be found in the literature: Xu, M., et al., Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1,2-fucosyltransferase from Bacillus cereus. Microbial Cell Factories, 2021.20(1): p.165.
以半乳糖诱导型启动子Pgal表达3’-FL合成途径的菌株FL303作为Kα-EGE4-3FL菌株的对照，该菌株的构建方法与菌株FL06的构建方法相同，不同之处仅在于用α-1,3-岩藻糖基转移酶基因fut3Bc(SEQ ID NO.2)替换了α-1,2-岩藻糖基转移酶基因futBc。The strain FL303 expressing the 3'-FL synthesis pathway with the galactose-inducible promoter P gal was used as a control for the Kα-EGE4-3FL strain. The construction method of this strain was the same as that of the strain FL06, except that the α-1,2-fucosyltransferase gene futBc was replaced by the α-1,3-fucosyltransferase gene fut3Bc (SEQ ID NO.2).
3、发酵生产2’-FL的过程如下：3. The process of fermentation production of 2'-FL is as follows:
将菌株Kα-EGE4-2FL和对照菌株FL06的菌液接种至带有5mL的YPD液体培养基(添加20g/L葡萄糖和0.06g/L adenine sulfate)中，在30℃，200rpm下震荡培养24h后，接种于带有20mLYPD液体培养基(添加20g/L葡萄糖和0.06g/L adenine sulfate)中，调整接种量，使发酵液的初始OD为约0.2，继续在摇床中30℃，200rpm震荡培养24h后，菌株Kα-EGE4-2FL补加30g/L的葡萄糖，4g/L的乳糖，其对照菌株FL06补加30g/L的半乳糖，4g/L的乳糖，发酵产物中的2’-FL产量如图6所示。The bacterial culture of strain Kα-EGE4-2FL and control strain FL06 was inoculated into 5 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate), and cultured at 30°C, 200 rpm for 24 h. Then, the culture was inoculated into 20 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate). The inoculation amount was adjusted so that the initial OD of the fermentation broth was about 0.2. After continuing to culture in a shaker at 30°C, 200 rpm for 24 h, the strain Kα-EGE4-2FL was supplemented with 30 g/L glucose and 4 g/L lactose, and the control strain FL06 was supplemented with 30 g/L galactose and 4 g/L lactose. The 2’-FL yield in the fermentation product is shown in Figure 6.
由图6可知，菌株Kα-EGE4-2FL中2’-FL产量在48h时即达到最高值3.37g/L，该产量 为48h时对照菌株FL06产量的2.6倍，明显提高了2’-FL合成效率。As shown in Figure 6, the 2'-FL production in strain Kα-EGE4-2FL reached a maximum of 3.37 g/L at 48 h. The yield was 2.6 times that of the control strain FL06 at 48h, which significantly improved the 2'-FL synthesis efficiency.
4、发酵生产3’-FL的过程如下：4. The process of fermentation production of 3'-FL is as follows:
将菌株Kα-EGE4-2FL和对照菌株FL303的菌液接种至带有5mL的YPD液体培养基(添加20g/L葡萄糖和0.06g/L adenine sulfate)中，在30℃，200rpm下震荡培养24h后，接种于带有20mL YPD液体培养基(添加20g/L葡萄糖和0.06g/L adenine sulfate)中，调整接种量，使发酵液的初始OD为约0.2，继续在摇床中30℃，200rpm震荡培养24h后，菌株Kα-EGE4-3FL补加30g/L的葡萄糖，2g/L的乳糖，其对照菌株FL303补加30g/L的半乳糖，2g/L的乳糖，发酵产物中的3’-FL产量如图7所示。The bacterial culture of strain Kα-EGE4-2FL and control strain FL303 was inoculated into 5 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate), and cultured at 30°C, 200 rpm for 24 h. Then, the culture was inoculated into 20 mL of YPD liquid culture medium (added with 20 g/L glucose and 0.06 g/L adenine sulfate). The inoculation amount was adjusted so that the initial OD of the fermentation broth was about 0.2. After continuing to culture at 30°C, 200 rpm in a shaker for 24 h, the strain Kα-EGE4-3FL was supplemented with 30 g/L glucose and 2 g/L lactose, and the control strain FL303 was supplemented with 30 g/L galactose and 2 g/L lactose. The 3’-FL yield in the fermentation product is shown in Figure 7.
由图7可知，菌株Kα-EGE4-3FL在96h时合成的3’-FL产量为2.36g/L，该产量96h对照菌株FL303产量的2.5倍，明显提高了3’-FL合成效率。 As shown in FIG7 , the 3'-FL production of strain Kα-EGE4-3FL at 96 h was 2.36 g/L, which was 2.5 times the production of the control strain FL303 at 96 h, significantly improving the 3'-FL synthesis efficiency.

Claims (15)

  1. 一种提高基因表达水平的酿酒酵母工程菌，其特征在于，是以酿酒酵母W303-1a为出发菌株，该酿酒酵母工程菌敲除了胞外蛋白酶编码基因bar1和半乳糖代谢途径抑制因子编码基因gal80，同时含有以启动子Pvrg4表达的乳酸克鲁维酵母来源的Kα因子编码基因kmfα1和以启动子Pfus1表达的转录激活因子编码基因gal4。A brewer's yeast engineered bacterium for improving gene expression levels, characterized in that the brewer's yeast W303-1a is used as a starting strain, the brewer's yeast engineered bacterium has knocked out the extracellular protease encoding gene bar1 and the galactose metabolic pathway inhibitor encoding gene gal80, and contains the Kα factor encoding gene kmfα1 from lactic acid Kluyveromyces lactis expressed by the promoter P vrg4 and the transcription activator encoding gene gal4 expressed by the promoter P fus1 .
  2. 权利要求1所述的酿酒酵母工程菌的构建方法，其特征在于，包括步骤：以酿酒酵母W303-1a为出发菌株，敲除bar1基因，然后转化含有启动子Pvrg4和Kα因子编码基因kmfα1的重组载体pRS304-Pvrg4-kmfα1-Tcyc1，将gal4编码基因的原始启动子替换为Pfus1，再转化融合片段Pfus1-gal4，最后敲除gal80基因，经筛选、验证获得。The method for constructing an engineered yeast of claim 1 is characterized in that it comprises the steps of: using Saccharomyces cerevisiae W303-1a as a starting strain, knocking out the bar1 gene, then transforming the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 containing the promoter P vrg4 and the Kα factor encoding gene kmfα1, replacing the original promoter of the gal4 encoding gene with P fus1 , then transforming the fusion fragment P fus1 -gal4, and finally knocking out the gal80 gene, and obtaining it through screening and verification.
  3. 如权利要求2所述提高基因表达水平的酿酒酵母工程菌的构建方法，其特征在于，具体包括步骤如下：The method for constructing an engineered strain of Saccharomyces cerevisiae for improving gene expression level according to claim 2, characterized in that the method comprises the following steps:
    (1)以质粒pUMRI-A中两端带有loxp序列(CRE酶切割位点)的kanMX遗传霉素标记基因为模板，以Bar1-g418-UP-F和Bar1-g418-down-R为引物进行PCR扩增，得到bar1基因的敲除组件；然后bar1基因的敲除组件转化至酿酒酵母菌株W303-1a，经筛选后得到敲除胞外蛋白酶Bar1编码基因的菌株Bar1Δ；(1) Using the kanMX geneticin marker gene with loxp sequences (CRE enzyme cleavage sites) at both ends in the plasmid pUMRI-A as a template, PCR amplification was performed with Bar1-g418-UP-F and Bar1-g418-down-R as primers to obtain the knockout component of the bar1 gene; then the knockout component of the bar1 gene was transformed into the Saccharomyces cerevisiae strain W303-1a, and after screening, the strain Bar1Δ in which the gene encoding the extracellular protease Bar1 was knocked out was obtained;
    (2)人工合成密码子优化后的α因子编码基因kmfα1序列，然后进行PCR扩增，得到优化后的kmfα1序列；以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到启动子Pvrg4和终止子Tcyc1；将Pvrg4、优化后的kmfα1序列和Tcyc1进行融合PCR，再将融合PCR产物Pvrg4-kmfα1-Tcyc1连接到质粒pRS304上，得到重组载体pRS304-Pvrg4-kmfα1-Tcyc1；将重组载体pRS304-Pvrg4-kmfα1-Tcyc1转化至菌株Bar1Δ中，经筛选后得菌株VRG4p-Kα；(2) Artificially synthesizing the codon-optimized α-factor encoding gene kmfα1 sequence, and then performing PCR amplification to obtain the optimized kmfα1 sequence; performing PCR amplification using the genomic DNA of Saccharomyces cerevisiae W303-1a as a template to obtain the promoter P vrg4 and the terminator T cyc1 ; performing fusion PCR on P vrg4 , the optimized kmfα1 sequence and T cyc1 , and then connecting the fusion PCR product P vrg4 -kmfα1-T cyc1 to the plasmid pRS304 to obtain the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 ; transforming the recombinant vector pRS304-P vrg4 -kmfα1-T cyc1 into the strain Bar1Δ, and obtaining the strain VRG4p-Kα after screening;
    (3)以酿酒酵母W303-1a基因组DNA为模板进行PCR扩增，得到带有启动子Pgal4下游同源臂序列的启动子Pfus1，以pUMRI-A质粒为模板进行PCR扩增，得到带有Pgal4上游同源臂序列的kanMX编码序列；将启动子Pfus1和kanMX序列进行融合PCR扩增，得融合PCR产物Pfus1-gal4片段；将Pfus1-gal4片段转化至菌株VRG4p-Kα，经筛选后得菌株Kα-EGE1；(3) Using the genomic DNA of Saccharomyces cerevisiae W303-1a as a template, PCR amplification was performed to obtain the promoter P fus1 with the downstream homology arm sequence of the promoter P gal4 , and PCR amplification was performed using the pUMRI-A plasmid as a template to obtain the kanMX coding sequence with the upstream homology arm sequence of P gal4 ; the promoter P fus1 and kanMX sequences were fused PCR amplified to obtain the fusion PCR product P fus1 -gal4 fragment; the P fus1 -gal4 fragment was transformed into the strain VRG4p-Kα, and the strain Kα-EGE1 was obtained after screening;
    (4)以质粒pUMRI-A的kanMX遗传霉素标记基因为模板，以Gal80-knockout-F/R为引物进行PCR扩增，，得到gal80基因的敲除组件；然后将，得到gal80基因的敲除组件转化至酿酒酵母菌株Kα-EGE1，经筛选后得到提高基因表达水平的酿酒酵母工程菌Kα-EGE2。(4) Using the kanMX geneticin marker gene of plasmid pUMRI-A as a template and Gal80-knockout-F/R as primers, PCR amplification was performed to obtain the knockout component of the gal80 gene; then, the knockout component of the gal80 gene was transformed into the cerevisiae Saccharomyces cerevisiae strain Kα-EGE1, and after screening, the cerevisiae engineered strain Kα-EGE2 with improved gene expression level was obtained.
  4. 如权利要求3所述提高基因表达水平的酿酒酵母工程菌的构建方法，其特征在于，所述Bar1-g418-UP-F带有bar1上游50 bp同源臂，Bar1-g418-down-R带有bar1下游50 bp同源臂，具体序列如下：The method for constructing an engineered yeast strain for improving gene expression level according to claim 3, characterized in that the Bar1-g418-UP-F carries a 50 bp homology arm upstream of bar1, and the Bar1-g418-down-R carries a 50 bp homology arm downstream of bar1, and the specific sequences are as follows:
    Bar1-g418-UP-F:5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′， Bar1-g418-UP-F: 5′-TAACATGTATACACAGCCAGCTATTCTGAAACACACCACATTATAGATAACTTCGTATAATGTATGC-3′,
    Bar1-g418-down-R:5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′。Bar1-g418-down-R: 5′-ATAATGTGCTACTTGTTCAAAATTGTGATGGCTGCATAATATTACATAACTTCGTATAGCATAC-3′.
  5. 如权利要求3所述提高基因表达水平的酿酒酵母工程菌的构建方法，其特征在于，步骤(2)中，所述α因子来自于克鲁维酵母，核苷酸序列如SEQ ID NO.1所示，PCR扩增引物序列如下：The method for constructing an engineered yeast of brewer's yeast for improving gene expression level as claimed in claim 3, characterized in that in step (2), the α factor is derived from Kluyveromyces, the nucleotide sequence is shown in SEQ ID NO.1, and the PCR amplification primer sequence is as follows:
    KMFa1-F:5′-ATGAAATTCTCTACTATATTAG-3′，KMFa1-F: 5′-ATGAAATTCTCTACTATATTAG-3′,
    KMFa1-R:5′-ATTACATGATCAGAAAATTGGTTGGCC-3′；KMFa1-R: 5′-ATTACATGATCAGAAAATTGGTTGGCC-3′;
    所述启动子Pvrg4的PCR扩增引物序列如下：The PCR amplification primer sequence of the promoter P vrg4 is as follows:
    304-BamHI-VRG4p-F:5′-CGCTCTAGAACTAGTGGATCCCAAACAACAATTTCAACAG-3′，304-BamHI-VRG4p-F:5′-CGCTCTAGAACTAGTGGATCCCAAACAACAATTTCAACAG-3′,
    VRG4p-mfa1-R:5′-TATAGTAGAGAATTTCATTCGGGCGAAAGATACTG-3′；VRG4p-mfa1-R:5′-TATAGTAGAGAATTTCATTCGGGCGAAAGATACTG-3′;
    所述终止子Tcyc1的PCR引物序列如下：The PCR primer sequence of the terminator T cyc1 is as follows:
    CYC1t-kmfa1-F:5′-CAATTTTCTGATCATGTAATTAGTTATG-3′；CYC1t-kmfa1-F:5′-CAATTTTCTGATCATGTAATTAGTTATG-3′;
    304-XhoI-CYC1t-R:5′-GTACCGGGCCCCCCCTCGAGGCAAATTAAAGCCTTCG-3′。304-XhoI-CYC1t-R:5′-GTACCGGGCCCCCCCTCGAGGCAAATTAAAGCCTTCG-3′.
  6. 如权利要求3所述提高基因表达水平的酿酒酵母工程菌的构建方法，其特征在于，步骤(3)中，所述带有启动子Pgal4下游同源臂的启动子Pfus1的PCR引物序列如下：The method for constructing an engineered strain of Saccharomyces cerevisiae for improving gene expression level as claimed in claim 3, characterized in that, in step (3), the PCR primer sequence of the promoter P fus1 with the downstream homology arm of the promoter P gal4 is as follows:
    Fus1-F:5′-ATCAACAACAGGGTCAGC-3′；Fus1-F: 5′-ATCAACAACAGGGTCAGC-3′;
    fus1-down-pgal4-R:5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′；fus1-down-pGal4-R:5′-TTAAGTCGGCAAATATCGCATGCTTGTTCGATAGAAGACAGTAGCTTCATTTTGATTTTCAGAAACTTGATG-3′;
    所述带有启动子Pgal4上游同源臂的kanMX遗传霉素标记基因的PCR扩增引物序列如下：The PCR amplification primer sequence of the kanMX geneticin marker gene with the upstream homology arm of the promoter P gal4 is as follows:
    UP-Pgal4-G418-F:5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′，UP-Pgal4-G418-F: 5′-TCAAAGTATTTACATAATTCTGTATCAGTTTAATCACCATAATATCGTTTATAACTTCGTATAATGTATG-3′,
    G418-fus-R:5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′；G418-fus-R:5′-GCTGACCCTGTTGTTGATATAACTTCGTATAGC-3′;
    所述融合PCR中启动子Pfus1和转录激活因子gal4的摩尔比为1:1。The molar ratio of the promoter P fus1 and the transcription activator gal4 in the fusion PCR is 1:1.
  7. 如权利要求3所述提高基因表达水平的酿酒酵母工程菌的构建方法，其特征在于，步骤(4)中，所述Gal80-knockout-F带有gal80上游50 bp同源臂，Gal80-knockout-R带有gal80下游50 bp同源臂，具体序列如下：The method for constructing an engineered yeast of Saccharomyces cerevisiae for improving gene expression level as claimed in claim 3, characterized in that, in step (4), the Gal80-knockout-F carries a 50 bp homology arm upstream of gal80, and the Gal80-knockout-R carries a 50 bp homology arm downstream of gal80, and the specific sequences are as follows:
    Gal80-knockout-F:5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′；Gal80-knockout-F: 5′-GTATACAATCTCGATAGTTGGTTTCCCGTTCTTTCCACTCCCGTCTAACTTCGTATAATGTATGC-3′;
    Gal80-knockout-R:5′- TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′。Gal80-knockout-R:5′- TTACCCACAATGGCATTATAATTTCGTAAATGATATACTTCCATGATAACTTCGTATAGCATAC-3′.
  8. 权利要求1所述的提高基因表达水平的酿酒酵母工程菌在构建表达外源基因的基因工程菌中的应用。Use of the brewer's yeast engineered bacteria with improved gene expression level as claimed in claim 1 in constructing genetically engineered bacteria for expressing exogenous genes.
  9. 如权利要求8所述的应用，其特征在于，所述表达外源基因的基因工程菌为含有外源基因或含该外源基因的载体的菌株，所述菌株的基因组中整合了所述外源基因。The use according to claim 8 is characterized in that the genetically engineered bacteria expressing the exogenous gene is a strain containing the exogenous gene or a vector containing the exogenous gene, and the exogenous gene is integrated into the genome of the strain.
  10. 如权利要求9所述的应用，其特征在于，所述外源基因为工业、饲料或食品领域中用到的蛋白的编码序列；The use according to claim 9, characterized in that the exogenous gene is a coding sequence of a protein used in the field of industry, feed or food;
    进一步优选的，所述外源基因为酶的编码序列，所述酶为糖基转移酶；所述外源基因为α-1,3-岩藻糖基转移酶基因或α-1,2-岩藻糖基转移酶基因。Further preferably, the exogenous gene is a coding sequence of an enzyme, and the enzyme is a glycosyltransferase; the exogenous gene is an α-1,3-fucosyltransferase gene or an α-1,2-fucosyltransferase gene.
  11. 一株高产3-岩藻糖基乳糖的基因工程菌，其特征在于，所述基因工程菌同时表达乳糖透性酶、GDP-甘露糖脱氢酶、GDP-岩藻糖合成酶和α-1,3-岩藻糖基转移酶。A genetically engineered bacterium with high production of 3-fucosyllactose, characterized in that the genetically engineered bacterium simultaneously expresses lactose permease, GDP-mannose dehydrogenase, GDP-fucose synthase and α-1,3-fucosyltransferase.
  12. 如权利要求11所述的高产3-岩藻糖基乳糖的基因工程菌，其特征在于，所述基因工程菌为重组的酿酒酵母，所述酿酒酵母为酿酒酵母W303-1a。The genetically engineered bacterium with high yield of 3-fucosyllactose as claimed in claim 11, characterized in that the genetically engineered bacterium is a recombinant Saccharomyces cerevisiae, and the Saccharomyces cerevisiae is Saccharomyces cerevisiae W303-1a.
  13. 如权利要求12所述的高产3-岩藻糖基乳糖的基因工程菌，其特征在于，所述乳糖透性酶为来自克鲁维斯酵母的乳糖透性酶，其编码基因为Lac12，Genbank登录号为X06997.1。The genetically engineered bacterium with high production of 3-fucosyllactose according to claim 12, characterized in that the lactose permease is a lactose permease from Kluyveromyces cerevisiae, the encoding gene of which is Lac12, and the Genbank accession number is X06997.1.
  14. 如权利要求13所述的高产3-岩藻糖基乳糖的基因工程菌，其特征在于，所述GDP-甘露糖脱氢酶为来自大肠杆菌K12的GDP-甘露糖脱氢酶，其编码基因为Gmd，Genbank登录号为WP_182915037.1。The genetically engineered bacterium with high production of 3-fucosyllactose as claimed in claim 13, characterized in that the GDP-mannose dehydrogenase is GDP-mannose dehydrogenase from Escherichia coli K12, whose encoding gene is Gmd and whose Genbank accession number is WP_182915037.1.
  15. 如权利要求14所述的高产3-岩藻糖基乳糖的基因工程菌，其特征在于，所述GDP-岩藻糖合成酶为来自大肠杆菌K12的GDP-岩藻糖合成酶，其编码基因为WcaG，Genbank登录号为WP_000043654.1。 The genetically engineered bacterium with high production of 3-fucosyllactose as claimed in claim 14, characterized in that the GDP-fucose synthase is a GDP-fucose synthase from Escherichia coli K12, whose encoding gene is WcaG and whose Genbank accession number is WP_000043654.1.
PCT/CN2023/122447 2022-09-28 2023-09-28 Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof WO2024067774A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN202211192432.8A CN115806889B (en) 2022-09-28 2022-09-28 Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof
CN202211192432.8 2022-09-28
CN202211193388.2A CN115806890A (en) 2022-09-28 2022-09-28 Genetically engineered bacterium for high yield of 3-fucosyllactose and construction method and application thereof
CN202211193388.2 2022-09-28

Publications (1)

Publication Number Publication Date
WO2024067774A1 true WO2024067774A1 (en) 2024-04-04

Family

ID=90476315

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2023/122447 WO2024067774A1 (en) 2022-09-28 2023-09-28 Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof

Country Status (1)

Country Link
WO (1) WO2024067774A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111471605A (en) * 2020-03-17 2020-07-31 山东大学 Saccharomyces cerevisiae engineering strain for high yield of fucosyllactose and application thereof
CN111471606A (en) * 2020-03-17 2020-07-31 山东大学 Optimized saccharomyces cerevisiae strain capable of producing fucosyllactose at high yield and application thereof
US20210214705A1 (en) * 2018-05-15 2021-07-15 The Board Of Trustees Of The University Of Illinois Engineered microorganisms for production of 2'fucosyllactose and l-fucose
CN115806889A (en) * 2022-09-28 2023-03-17 山东大学 Saccharomyces cerevisiae engineering bacterium capable of improving gene expression level and construction method and application thereof
CN115806890A (en) * 2022-09-28 2023-03-17 山东大学 Genetically engineered bacterium for high yield of 3-fucosyllactose and construction method and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210214705A1 (en) * 2018-05-15 2021-07-15 The Board Of Trustees Of The University Of Illinois Engineered microorganisms for production of 2'fucosyllactose and l-fucose
CN111471605A (en) * 2020-03-17 2020-07-31 山东大学 Saccharomyces cerevisiae engineering strain for high yield of fucosyllactose and application thereof
CN111471606A (en) * 2020-03-17 2020-07-31 山东大学 Optimized saccharomyces cerevisiae strain capable of producing fucosyllactose at high yield and application thereof
CN115806889A (en) * 2022-09-28 2023-03-17 山东大学 Saccharomyces cerevisiae engineering bacterium capable of improving gene expression level and construction method and application thereof
CN115806890A (en) * 2022-09-28 2023-03-17 山东大学 Genetically engineered bacterium for high yield of 3-fucosyllactose and construction method and application thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"Principles and applications of genetic engineering", 31 January 2004, CHINA AGRICULTURE PRESS, CN, ISBN: 7-109-08557-0, article CHEN, HONG: "Yeast Expression System", pages: 218 - 219, XP009554840 *
A. GROSS, G. RÖDEL, K. OSTERMANN: "Application of the yeast pheromone system for controlled cell-cell communication and signal amplification.", LETTERS IN APPLIED MICROBIOLOGY, WILEY-BLACKWELL PUBLISHING LTD., GB, vol. 52, no. 5, 31 May 2011 (2011-05-31), GB , pages 521 - 526, XP009553466, ISSN: 0266-8254, DOI: 10.1111/j.1472-765X.2011.03035.x *
MINGYUAN XU: "Improved production of 2′-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1, 2-fucosyltransferase from Bacillus cereus", MICROBIAL CELL FACTORIES, SPRINGER, vol. 20, no. 1, 1 December 2021 (2021-12-01), XP093152242, ISSN: 1475-2859, DOI: 10.1186/s12934-021-01657-5 *
STAGOJ, M.N. ; COMINO, A. ; KOMEL, R.: "Fluorescence based assay of GAL system in yeast Saccharomyces cerevisiae", FEMS MICROBIOLOGY LETTERS, NO LONGER PUBLISHED BY ELSEVIER, vol. 244, no. 1, 1 March 2005 (2005-03-01), pages 105 - 110, XP027871683, ISSN: 0378-1097 *

Similar Documents

Publication Publication Date Title
KR102229968B1 (en) Expression constructs and methods for genetically engineering methyltrophic yeast
CN101128581B (en) Mutant aox 1 promoters
EP0201239B1 (en) Process for the isolation of fermentation products
CN115806889B (en) Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof
JP5350806B2 (en) System for producing aromatic molecules by biotransformation
EP0260404B1 (en) Amylolytic enzymes producing microorganisms constructed by recombinant DNA technology and their use for fermentation processes
JP6864308B2 (en) Isoamyl Acetate High Productivity, Acetic Acid Productivity Low Productivity and Isoamyl Alcohol High Productivity Method for Producing Brewed Yeast
WO2024067774A1 (en) Saccharomyces cerevisiae engineering bacteria for improving gene expression level and construction method and application thereof
CN106399139B (en) A method of improving saccharomyces cerevisiae isoprene synthesis capability
EP3356534B1 (en) Novel episomal plasmid vectors
JP5682866B2 (en) Molecular breeding method of yeast having excellent stress tolerance and genetically modified yeast
JPH09501842A (en) Cloned pullulanase
Janse et al. Expression of the Klebsiella pneumoniae pullulanase-encoding gene in Saccharomyces cerevisiae
WO2003080830A1 (en) Modified promoter
Kirk et al. Growth rate influences MFα1 promoter activity in MATα Saccharomyces cerevisiae
EP3530739B1 (en) Expression system for productin of a heterologous protein, plasmid expression vectors, method of construction of a recombinant strain of psychrotolerant yeast debaryomyces macquariensis and method of protein production by the recombinant yeast strain
US5541084A (en) Hybrid yeast promoter comprising an ENO2 UAS and TATA region and an additional UAS located between said ENO2 UAS and TATA region
WO2023104896A1 (en) Improved production of secreted proteins in fungal cells
JP2607509B2 (en) Method for producing alcohol by glucoamylase-producing transformed yeast
ITMI990065A1 (en) PRODUCTION OF HETEROLOGICAL PROTEINS FROM ZYGOSACCHAROMYCES BAILII
KR100278109B1 (en) Method for preparing human plasma albumin using transformed yeast Saccharomyces cerevisiae containing human plasma albumin expression vector
JPS63501767A (en) Truncated phosphoglycerate kinase promoter
KR101241346B1 (en) Osmosis―Resistant Yeast Strains and Uses Thereof
JP2006238852A (en) Method for transforming yeast by peptide transport enzyme gene and method for expressing protein using promoter domain of the gene
Wang et al. Cloning of the Aspergillus awamori glucoamylase gene and expression in Saccharomyces cerevisiae

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23870999

Country of ref document: EP

Kind code of ref document: A1